0001674440 false Q1 --04-30 MD P0Y 0001674440 2023-05-01 2023-07-31 0001674440 2023-10-02 0001674440 2023-07-31 0001674440 2023-04-30 0001674440 us-gaap:NonrelatedPartyMember 2023-07-31 0001674440 us-gaap:NonrelatedPartyMember 2023-04-30 0001674440 us-gaap:RelatedPartyMember 2023-07-31 0001674440 us-gaap:RelatedPartyMember 2023-04-30 0001674440 2022-05-01 2022-07-31 0001674440 us-gaap:NonrelatedPartyMember 2023-05-01 2023-07-31 0001674440 us-gaap:NonrelatedPartyMember 2022-05-01 2022-07-31 0001674440 us-gaap:RelatedPartyMember 2023-05-01 2023-07-31 0001674440 us-gaap:RelatedPartyMember 2022-05-01 2022-07-31 0001674440 us-gaap:CommonStockMember 2022-04-30 0001674440 us-gaap:AdditionalPaidInCapitalMember 2022-04-30 0001674440 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-30 0001674440 us-gaap:RetainedEarningsMember 2022-04-30 0001674440 2022-04-30 0001674440 us-gaap:CommonStockMember 2023-04-30 0001674440 us-gaap:AdditionalPaidInCapitalMember 2023-04-30 0001674440 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-30 0001674440 us-gaap:RetainedEarningsMember 2023-04-30 0001674440 us-gaap:CommonStockMember 2022-05-01 2022-07-31 0001674440 us-gaap:AdditionalPaidInCapitalMember 2022-05-01 2022-07-31 0001674440 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-05-01 2022-07-31 0001674440 us-gaap:RetainedEarningsMember 2022-05-01 2022-07-31 0001674440 us-gaap:CommonStockMember 2023-05-01 2023-07-31 0001674440 us-gaap:AdditionalPaidInCapitalMember 2023-05-01 2023-07-31 0001674440 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-05-01 2023-07-31 0001674440 us-gaap:RetainedEarningsMember 2023-05-01 2023-07-31 0001674440 us-gaap:CommonStockMember 2022-07-31 0001674440 us-gaap:AdditionalPaidInCapitalMember 2022-07-31 0001674440 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-31 0001674440 us-gaap:RetainedEarningsMember 2022-07-31 0001674440 2022-07-31 0001674440 us-gaap:CommonStockMember 2023-07-31 0001674440 us-gaap:AdditionalPaidInCapitalMember 2023-07-31 0001674440 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-31 0001674440 us-gaap:RetainedEarningsMember 2023-07-31 0001674440 CNXA:SlingerBagAmericasIncMember 2019-08-23 0001674440 CNXA:SlingerBagAmericasIncMember CNXA:StockPurchaseAgreementMember 2019-08-23 2019-08-23 0001674440 CNXA:StockPurchaseAgreementMember CNXA:SlingerBagAmericasIncMember 2019-08-23 0001674440 CNXA:SlingerBagAmericasIncMember 2019-09-16 2019-09-16 0001674440 CNXA:SlingerBagAmericasIncMember 2019-09-16 0001674440 CNXA:SoleShareholderofSBLMember CNXA:StockPurchaseAgreementMember 2019-09-16 2019-09-16 0001674440 CNXA:SoleShareholderofSBLMember 2019-09-16 0001674440 CNXA:SlingerBagAmericasIncMember 2020-02-10 0001674440 CNXA:FoundationSportsSystemsLLCMember CNXA:CharlesRuddyMember 2021-06-21 0001674440 CNXA:FoundationSportsSystemsLLCMember 2022-12-05 0001674440 2022-06-14 2022-06-14 0001674440 us-gaap:SubsequentEventMember 2023-09-22 2023-09-22 0001674440 srt:MinimumMember us-gaap:SubsequentEventMember 2023-10-09 0001674440 srt:MinimumMember 2023-07-26 0001674440 CNXA:PlaySightMember CNXA:FoundationSportsSystemsLLCMember 2022-11-30 0001674440 CNXA:PlaySightMember CNXA:FoundationSportsSystemsLLCMember 2022-12-31 0001674440 CNXA:FoundationSportsSystemsLLCMember 2023-05-01 2023-07-31 0001674440 CNXA:FoundationSportsSystemsLLCMember 2023-07-31 0001674440 us-gaap:FairValueInputsLevel3Member 2023-05-01 2023-07-31 0001674440 us-gaap:FairValueInputsLevel3Member 2022-05-01 2023-04-30 0001674440 us-gaap:WarrantMember 2023-05-01 2023-07-31 0001674440 CNXA:ProfitGuarantyMember 2023-07-31 0001674440 CNXA:ProfitGuarantyMember 2023-05-01 2023-07-31 0001674440 CNXA:ConvertibleNotesMember 2023-07-31 0001674440 CNXA:ConvertibleNotesMember 2023-05-01 2023-07-31 0001674440 CNXA:UnderwriterWarrantsMember 2023-07-31 0001674440 CNXA:UnderwriterWarrantsMember 2023-05-01 2023-07-31 0001674440 CNXA:WarrantsIssuedWithCommonStockMember 2023-07-31 0001674440 CNXA:WarrantsIssuedWithCommonStockMember 2023-05-01 2023-07-31 0001674440 CNXA:WarrantsIssuedWithNotesPayableMember 2023-07-31 0001674440 CNXA:WarrantsIssuedWithNotesPayableMember 2023-05-01 2023-07-31 0001674440 srt:MinimumMember us-gaap:MeasurementInputExpectedTermMember us-gaap:ValuationTechniqueOptionPricingModelMember 2023-05-01 2023-07-31 0001674440 srt:MaximumMember us-gaap:MeasurementInputExpectedTermMember us-gaap:ValuationTechniqueOptionPricingModelMember 2023-05-01 2023-07-31 0001674440 srt:MinimumMember us-gaap:MeasurementInputExpectedTermMember us-gaap:ValuationTechniqueOptionPricingModelMember 2022-05-01 2022-07-31 0001674440 srt:MaximumMember us-gaap:MeasurementInputExpectedTermMember us-gaap:ValuationTechniqueOptionPricingModelMember 2022-05-01 2022-07-31 0001674440 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2023-07-31 0001674440 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember srt:MinimumMember 2022-07-31 0001674440 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember srt:MaximumMember 2022-07-31 0001674440 srt:MinimumMember us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:ValuationTechniqueOptionPricingModelMember 2023-07-31 0001674440 srt:MaximumMember us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:ValuationTechniqueOptionPricingModelMember 2023-07-31 0001674440 srt:MinimumMember us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:ValuationTechniqueOptionPricingModelMember 2022-07-31 0001674440 srt:MaximumMember us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:ValuationTechniqueOptionPricingModelMember 2022-07-31 0001674440 us-gaap:MeasurementInputExpectedDividendRateMember us-gaap:ValuationTechniqueOptionPricingModelMember 2023-07-31 0001674440 us-gaap:MeasurementInputExpectedDividendRateMember us-gaap:ValuationTechniqueOptionPricingModelMember 2022-07-31 0001674440 us-gaap:WarrantMember us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:MeasurementInputExpectedTermMember 2023-07-31 0001674440 us-gaap:WarrantMember us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:MeasurementInputExpectedTermMember srt:MinimumMember 2022-07-31 0001674440 us-gaap:WarrantMember us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:MeasurementInputExpectedTermMember srt:MaximumMember 2022-07-31 0001674440 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:WarrantMember 2023-07-31 0001674440 srt:MinimumMember us-gaap:MeasurementInputPriceVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:WarrantMember 2022-07-31 0001674440 srt:MaximumMember us-gaap:MeasurementInputPriceVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:WarrantMember 2022-07-31 0001674440 us-gaap:WarrantMember us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-07-31 0001674440 us-gaap:WarrantMember us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MinimumMember 2022-07-31 0001674440 us-gaap:WarrantMember us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MaximumMember 2022-07-31 0001674440 us-gaap:WarrantMember us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:MeasurementInputExpectedDividendRateMember 2023-07-31 0001674440 us-gaap:WarrantMember us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:MeasurementInputExpectedDividendRateMember 2022-07-31 0001674440 us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember CNXA:CustomerTwoMember 2023-05-01 2023-07-31 0001674440 us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember CNXA:CustomerTwoMember 2022-05-01 2023-04-30 0001674440 us-gaap:LenderConcentrationRiskMember CNXA:CustomerFourMember us-gaap:AccountsPayableMember 2023-05-01 2023-07-31 0001674440 us-gaap:LenderConcentrationRiskMember CNXA:CustomerFourMember us-gaap:AccountsPayableMember 2022-05-01 2023-04-30 0001674440 CNXA:TradeNamesAndPatentsMember 2023-07-31 0001674440 CNXA:TradeNamesAndPatentsMember 2023-05-01 2023-07-31 0001674440 us-gaap:CustomerRelationshipsMember 2023-07-31 0001674440 us-gaap:CustomerRelationshipsMember 2023-05-01 2023-07-31 0001674440 us-gaap:ComputerSoftwareIntangibleAssetMember 2023-07-31 0001674440 us-gaap:ComputerSoftwareIntangibleAssetMember 2023-05-01 2023-07-31 0001674440 CNXA:IntangiableAssetMember 2023-07-31 0001674440 CNXA:IntangiableAssetMember 2023-05-01 2023-07-31 0001674440 CNXA:TradeNamesAndPatentsMember 2023-04-30 0001674440 CNXA:TradeNamesAndPatentsMember 2022-05-01 2023-04-30 0001674440 us-gaap:CustomerRelationshipsMember 2023-04-30 0001674440 us-gaap:CustomerRelationshipsMember 2022-05-01 2023-04-30 0001674440 us-gaap:ComputerSoftwareIntangibleAssetMember 2023-04-30 0001674440 us-gaap:ComputerSoftwareIntangibleAssetMember 2022-05-01 2023-04-30 0001674440 CNXA:IntangiableAssetMember 2023-04-30 0001674440 CNXA:IntangiableAssetMember 2022-05-01 2023-04-30 0001674440 CNXA:FoundationSportsSystemsLLCMember 2023-05-01 2023-07-31 0001674440 us-gaap:PatentsMember 2023-07-31 0001674440 CNXA:LoanAgreementsMember us-gaap:RelatedPartyMember 2022-01-14 0001674440 CNXA:LoanAgreementsMember us-gaap:RelatedPartyMember 2022-01-13 2022-01-14 0001674440 us-gaap:RelatedPartyMember 2023-01-06 2023-01-06 0001674440 2023-01-06 0001674440 2022-06-17 2022-06-17 0001674440 2022-06-17 0001674440 CNXA:PromissoryNotePayableMember 2021-04-10 2021-04-11 0001674440 CNXA:PromissoryNotePayableMember 2021-04-11 0001674440 2021-04-10 2021-04-11 0001674440 us-gaap:ValuationTechniqueOptionPricingModelMember 2021-04-11 0001674440 CNXA:PromissoryNotePayableMember 2023-04-30 0001674440 CNXA:PromissoryNotePayableMember 2022-04-30 0001674440 2022-02-14 2022-02-15 0001674440 2022-05-01 2023-04-30 0001674440 2021-05-01 2022-07-31 0001674440 CNXA:NotesPayableMember 2022-04-01 0001674440 2022-04-01 2022-04-01 0001674440 2022-08-01 2022-08-01 0001674440 CNXA:UFSAgreementMember 2022-07-29 2022-07-29 0001674440 CNXA:UFSAgreementMember CNXA:EachWeekForNextThreeWeeksMember 2022-07-29 2022-07-29 0001674440 CNXA:UFSAgreementMember CNXA:ThereafterPerWeekMember 2022-07-29 2022-07-29 0001674440 CNXA:CedarAgreementMember 2022-07-29 2022-07-29 0001674440 CNXA:CedarAgreementMember CNXA:EachWeekForNextThreeWeeksMember 2022-07-29 2022-07-29 0001674440 CNXA:CedarAgreementMember CNXA:ThereafterPerWeekMember 2022-07-29 2022-07-29 0001674440 CNXA:LoanAndSecurityAgreementMember CNXA:ArmisticeCapitalMasterFundLtdMember srt:MaximumMember 2023-01-06 0001674440 CNXA:LoanAndSecurityAgreementMember CNXA:ArmisticeCapitalMasterFundLtdMember CNXA:NotesMember 2023-01-04 2023-01-06 0001674440 CNXA:LoanAndSecurityAgreementMember CNXA:ArmisticeCapitalMasterFundLtdMember 2023-01-06 0001674440 CNXA:LoanAndSecurityAgreementMember CNXA:ArmisticeCapitalMasterFundLtdMember 2023-01-04 2023-01-06 0001674440 us-gaap:WarrantMember CNXA:LoanAndSecurityAgreementMember CNXA:ArmisticeCapitalMasterFundLtdMember 2023-01-06 2023-01-06 0001674440 us-gaap:WarrantMember CNXA:LoanAndSecurityAgreementMember CNXA:ArmisticeCapitalMasterFundLtdMember 2023-01-06 0001674440 CNXA:LoanAndSecurityAgreementMember CNXA:ArmisticeCapitalMasterFundLtdMember 2023-07-31 2023-07-31 0001674440 CNXA:LoanAndSecurityAgreementMember CNXA:ArmisticeCapitalMasterFundLtdMember 2023-07-31 0001674440 CNXA:LoanAndSecurityAgreementMember CNXA:ArmisticeCapitalMasterFundLtdMember 2023-04-30 0001674440 CNXA:LoanAndSecurityAgreementMember CNXA:ArmisticeCapitalMasterFundLtdMember 2023-05-01 2023-07-31 0001674440 CNXA:MegedAgreementMember 2023-06-08 2023-06-08 0001674440 us-gaap:RelatedPartyMember 2022-07-31 0001674440 2022-06-15 2022-06-15 0001674440 us-gaap:InvestorMember 2022-06-15 2022-06-15 0001674440 CNXA:GabrielGoldmanMember 2022-06-27 2022-06-27 0001674440 CNXA:GamefaceAIMember 2022-06-27 2022-06-27 0001674440 CNXA:MidcityCapitalLtdMember 2022-08-25 2022-08-25 0001674440 CNXA:SecuritiesPurchaseAgreementMember us-gaap:InvestorMember 2022-09-28 2022-09-28 0001674440 CNXA:SecuritiesPurchaseAgreementMember us-gaap:InvestorMember 2022-09-28 0001674440 CNXA:SecuritiesPurchaseAgreementMember us-gaap:InvestorMember CNXA:FiveYearWarrantsMember 2022-09-28 0001674440 CNXA:SecuritiesPurchaseAgreementMember us-gaap:InvestorMember CNXA:SevenYearWarrantsMember 2022-09-28 2022-09-28 0001674440 CNXA:SecuritiesPurchaseAgreementMember us-gaap:InvestorMember CNXA:SevenPointFiveYearWarrantsMember 2022-09-28 0001674440 2022-10-12 2022-10-12 0001674440 2022-11-21 2022-11-21 0001674440 2023-01-26 2023-01-26 0001674440 CNXA:SecuritiesPurchaseAgreementMember us-gaap:InvestorMember CNXA:SevenPointFiveYearWarrantsMember 2022-09-28 2022-09-28 0001674440 CNXA:SecuritiesPurchaseAgreementMember us-gaap:InvestorMember 2023-01-31 0001674440 2023-01-31 0001674440 2022-06-01 2022-06-30 0001674440 2023-03-21 0001674440 srt:MinimumMember 2023-01-31 0001674440 CNXA:SharePurchaseAgreementMember 2022-11-25 2022-11-27 0001674440 CNXA:EmployeeAgreementMember 2022-11-27 0001674440 CNXA:SharePurchaseAgreementMember 2022-11-27 0001674440 CNXA:FoundationSportsToCharlesRuddyMember 2022-12-05 0001674440 2022-12-05 0001674440 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2023-08-01 2023-08-01 0001674440 us-gaap:CommonStockMember us-gaap:SubsequentEventMember CNXA:RodneyRapsonMember 2023-08-17 2023-08-17 0001674440 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2023-08-31 2023-08-31 0001674440 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2023-09-18 2023-09-18 0001674440 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2023-09-19 2023-09-19 0001674440 us-gaap:SubsequentEventMember CNXA:UFSAgreementMember 2023-08-07 2023-08-07 0001674440 us-gaap:SubsequentEventMember CNXA:UFSAgreementMember CNXA:EachWeekForNextThreeWeeksMember 2023-08-07 2023-08-07 0001674440 CNXA:AmendedUFSAgreementMember us-gaap:SubsequentEventMember 2023-08-21 2023-08-21 0001674440 us-gaap:SubsequentEventMember CNXA:SecondMegedAgreementMember 2023-09-19 2023-09-19 0001674440 us-gaap:SubsequentEventMember CNXA:SecondMegedAgreementMember CNXA:EachWeekForNextThreeWeeksMember 2023-09-19 2023-09-19 iso4217:USD xbrli:shares iso4217:USD xbrli:shares CNXA:Integer xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended July 31, 2023

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT

 

For the transition period from ________ to ________

 

Commission File Number: 01-41423

 

CONNEXA SPORTS TECHNOLOGIES INC.

(Exact name of registrant as specified in its charter)

 

Delaware   61-1789640

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

2709 NORTH ROLLING ROAD, SUITE 138

WINDSOR MILL,

MARYLAND 21244

(Address of principal executive offices, including Zip Code)

 

(443) 407-7564

(Registrant’s Telephone Number, including Area Code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.001 par value   CNXA   Nasdaq Capital Market

 

Securities registered pursuant to Section 12(g) of the Securities Exchange Act of 1934: None

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934. Yes ☐ No ☒

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Securities Exchange Act of 1934 Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer Smaller reporting company
  Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

 

The number of shares outstanding of the registrant’s Common Stock, $0.001 par value per share, as of October 2, 2023, was 773,975.

 

 

 

 
 

 

CAUTIONARY STATEMENT REGARDING FORWARD LOOKING INFORMATION

 

This quarterly report contains forward-looking statements within the meaning of Section 27A of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The words “believe,” “expect,” “anticipate,” “intend,” “estimate,” “may,” “should,” “could,” “will,” “plan,” “future,” “continue,” and other expressions that are predictions of or indicate future events and trends and that do not relate to historical matters identify forward-looking statements. These forward-looking statements are based largely on our expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond our control. Therefore, actual results could differ materially from the forward-looking statements contained in this document, and readers are cautioned not to place undue reliance on such forward-looking statements. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. A wide variety of factors could cause or contribute to such differences and could adversely impact revenues, profitability, cash flows and capital needs. There can be no assurance that the forward-looking statements contained in this document will, in fact, transpire or prove to be accurate. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including the risks in the section entitled “Risk Factors” in our Form 10-K for the fiscal year ended April 30, 2023, filed on September 14, 2023, that may cause our or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by any forward-looking statements.

 

Important factors that may cause the actual results to differ from the forward-looking statements, projections or other expectations include, but are not limited to, the following:

 

  risk that we will not be able to remediate identified material weaknesses in our internal control over financial reporting and disclosure controls and procedures;
     
  risk that we fail to meet the requirements of the agreements under which we acquired our business interests, including any cash payments to the business operations, which could result in the loss of our right to continue to operate or develop the specific businesses described in the agreements;
     
  risk that we will be unable to secure additional financing in the near future in order to commence and sustain our planned development and growth plans;
     
  risk that we cannot attract, retain and motivate qualified personnel, particularly employees, consultants and contractors for our operations;
     
  risks and uncertainties relating to the various industries and operations we are currently engaged in;
     
  results of initial feasibility, pre-feasibility and feasibility studies, and the possibility that future growth, development or expansion will not be consistent with our expectations;
     
  risks related to the inherent uncertainty of business operations including profit, cost of goods, production costs and cost estimates and the potential for unexpected costs and expenses;
     
  risks related to commodity price fluctuations;
     
  the uncertainty of profitability based upon our history of losses;
     
  risks related to failure to obtain adequate financing on a timely basis and on acceptable terms for our planned development projects;
     
  risks related to environmental regulation and liability;
     
  risks related to tax assessments; and
     
  other risks and uncertainties related to our prospects, properties and business strategy.

 

Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this report. Except as required by law, we do not undertake to update or revise any of the forward-looking statements to conform these statements to actual results, whether as a result of new information, future events or otherwise.

 

As used in this quarterly report, the “Connexa,” “Company,” “we,” “us,” or “our” refer to Connexa Sports Technologies Inc. and its subsidiaries, unless otherwise indicated.

 

i
 

 

CONNEXA SPORTS TECHNOLOGIES INC.

(FORMERLY KNOWN AS SLINGER BAG INC. AND LAZEX INC.)

 

INDEX

 

  Page
   
PART I - FINANCIAL INFORMATION: F-1
   
Item 1. Consolidated Financial Statements (Unaudited) F-1
   
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 1
   
Item 3. Quantitative and Qualitative Disclosures About Market Risk 7
   
Item 4. Controls and Procedures 8
   
PART II - OTHER INFORMATION: 9
   
Item 1. Legal Proceedings 9
   
Item 1A. Risk Factors 9
   
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 9
   
Item 6. Exhibits 11
   
SIGNATURES 12

 

ii
 

 

PART I - FINANCIAL INFORMATION

 

Item 1. Consolidated Financial Statements

 

CONNEXA SPORTS TECHNOLOGIES, INC.

CONSOLIDATED BALANCE SHEETS (IN US$)

JULY 31, 2023 (UNAUDITED) AND APRIL 30, 2023

 

   JULY 31, 2023   APRIL 30, 2023 
   (UNAUDITED)     
         
ASSETS          
Current Assets:          
Cash and cash equivalents  $386,459   $202,095 
Accounts receivable, net   444,622    399,680 
Inventories, net   2,336,918    3,189,766 
Prepaid inventory   1,134,368    936,939 
Prepaid expenses and other current assets   280,820    263,020 
           
Total Current Assets   4,583,187    4,991,500 
           
Non-Current Assets:          
Note receivable - former subsidiary   2,000,000    2,000,000 
Fixed assets, net of depreciation   -    14,791 
Intangible assets, net of amortization   1,000    101,281 
           
Total Non-Current Assets   2,001,000    2,116,072 
           
           
TOTAL ASSETS  $6,584,187   $7,107,572 
           
LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT)          
           
LIABILITIES          
Current Liabilities:          
Accounts payable  $6,087,311   $5,496,629 
Accrued expenses   5,197,460    4,911,839 
Accrued interest   41,522    25,387 
Accrued interest - related party   917,957    917,957 
Current portion of notes payable, net of discount   1,959,671    1,484,647 
Derivative liabilities   8,345,052    10,489,606 
Contingent consideration   418,455    418,455 
Other current liabilities   330,065    22,971 
           
Total Current Liabilities   23,297,493    23,767,491 
           
Long-Term Liabilities:          
Notes payable related parties, net of current portion   1,655,966    1,953,842 
           
Total Long-Term Liabilities   1,655,966    1,953,842 
           
Total Liabilities   24,953,459    25,721,333 
           
Commitments and contingency   -    - 
           
SHAREHOLDERS’ EQUITY (DEFICIT)          
           
Common stock, par value, $0.001, 300,000,000 shares authorized, 528,297 and 338,579 shares issued and outstanding as of July 31, 2023 and April 30, 2023, respectively   528    339 
Additional paid in capital   134,112,083    132,993,998 
Accumulated deficit   (152,597,375)   (151,750,610)
Accumulated other comprehensive income (loss)   115,492    142,512 
           
Total Stockholders’ Equity (Deficit)   (18,369,272)   (18,613,761)
           
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)  $6,584,187   $7,107,572 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

F-1
 

 

CONNEXA SPORTS TECHNOLOGIES, INC

CONSOLIDATED STATEMENTS OF OPERATIONS (IN US$) (UNAUDITED)

THREE MONTHS ENDED JULY 31, 2023 AND 2022

 

   2023   2022 
         
NET SALES  $3,120,231   $3,583,336 
           
COST OF SALES   2,227,482    2,562,044 
          .  
GROSS PROFIT   892,749    1,021,292 
           
OPERATING EXPENSES          
Selling and marketing expenses   242,353    756,823 
General and administrative expenses   2,505,060    3,314,610 
Research and development costs   -    19,425 
           
Total Operating Expenses   2,747,413    4,090,858 
           
OPERATING LOSS   (1,854,664)   (3,069,566)
           
NON-OPERATING INCOME (EXPENSE)          
Amortization of debt discounts   (777,192)   (2,872,222)
Loss on conversion of accounts payable to common stock   (289,980)   - 
Change in fair value of derivative liability   2,144,554    3,687,495 
Interest expense   (69,483)   (191,303)
Interest expense - related party   -    (61,121)
           
Total Non-Operating Income (Expenses)   1,007,899    562,849 
           
NET LOSS FROM CONTINUING OPERATIONS BEFORE PROVISION FOR INCOME TAXES   (846,765)   (2,506,717)
           
DISCONTINUED OPERATIONS          
Loss from discontinued operations   -    (1,759,714)
Loss on disposal of subsidiaries   -      
LOSS FROM DISCONTINUED OPERATIONS   -    (1,759,714)
           
NET LOSS FROM OPERATIONS BEFORE PROVISION FOR INCOME TAXES   (846,765)   (4,266,431)
           
Provision for income taxes   -    - 
           
NET LOSS  $(846,765)  $(4,266,431)
           
Other comprehensive income (loss)          
Foreign currency translations adjustment   (27,020)   58,139 
Comprehensive income (loss)  $(873,785)  $(4,208,292)
           
Net income (loss) per share - basic and diluted          
Continuing operations  $(1.93)  $(14.27)
Discontinued operations  $-   $(10.02)
           
Net loss per share - basic and diluted  $(1.93)  $(24.29)
           
Weighted average common shares outstanding - basic and diluted   438,354    175,653 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

F-2
 

 

CONNEXA SPORTS TECHNOLOGIES, INC

CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS’ EQUITY (DEFICIT) (IN US$) (UNAUDITED)

FOR THE THREE MONTHS ENDED JULY 31, 2023 AND 2022

 

               Accumulated         
       Additional   Other         
   Common Stock   Paid-In   Comprehensive   Accumulated     
   Shares   Amount   Capital   Income (Loss)   Deficit   Total 
                         
Balance - May 1, 2022   104,871   $105   $113,053,790   $54,962   $(80,596,925)  $32,511,932 
                               
Stock issued for:                              
Conversion of notes payable   109,737    110    14,046,190    -    -    14,046,300 
Acquisition   14,960    15    915,530    -    -    915,545 
Services   625    1    35,249    -    -    35,250 
Cash   26,219    26    4,194,974    -    -    4,195,000 
Fractional share issuance   38    -    -    -    -    - 
Share-based compensation   -    -    277,625    -    -    277,625 
Change in comprehensive income   -    -    -    58,139    -    58,139 
Net loss for the period   -    -    -    -    (4,266,431)   (4,266,431)
                               
Balance - July 31, 2022   256,450   $257   $132,523,358   $113,101   $(84,863,356)  $47,773,360 
                               
Balance - May 1, 2023   338,579   $339   $132,993,998   $142,512   $(151,750,610)  $(18,613,761)
                               
Stock issued for:                              
Services   188    -    -    -    -    - 
Accounts payable   67,500    67    559,913    -    -    559,980 
Acquisition   1,350    1    (1)   -    -    - 
Cashless exercise of warrants   27,000    27    (27)   -    -    - 
Satisfaction of profit guarantee on note payable   93,680    94    558,200    -    -    558,294 
Share-based compensation   -    -    -    -    -    - 
Change in comprehensive income   -    -    -    (27,020)   -    (27,020)
Net loss for the period   -    -    -    -    (846,765)   (846,765)
                               
Balance - July 31, 2023   528,297   $528   $134,112,083   $115,492   $(152,597,375)  $(18,369,272)

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

F-3
 

 

CONNEXA SPORTS TECHNOLOGIES, INC

CONSOLIDATED STATEMENTS OF CASH FLOWS (IN US$) (UNAUDITED)

THREE MONTHS ENDED JULY 31, 2023 AND 2022

 

   2023   2022 
CASH FLOW FROM OPERATING ACTIVITIES          
Net loss  $(846,765)  $(4,266,431)
Adjustments to reconcile net loss to net cash used in operating activities          
Depreciation, amortization and impairment expense   115,072    - 
Change in fair value of derivative liability   (2,144,554)   (3,687,495)
Shares and warrants issued for services   -    35,250 
Share-based compensation   -    277,625 
Amortization of debt discounts   777,192    2,872,222 
Settlement expense   558,294    - 
Loss on settlement of accounts payable   289,980    - 
Loss on conversion of convertible notes   -    - 
           
Changes in assets and liabilities, net of acquired amounts          
Accounts receivable   265,992    - 
Inventories   852,848    - 
Prepaid inventory   (197,429)   - 
Prepaid expenses and other current assets   (1,316)   - 
Accounts payable and accrued expenses   255,199    - 
Other current liabilities   326,550    - 
Accrued interest   16,135    - 
Accrued interest - related parties   -    - 
Total adjustments   1,113,963    (502,398)
           
Net cash used in operating activities of continuing operations   267,198    (4,768,829)
Net cash provided by operating activities of discontinued operations   -    - 
Net cash used in operating activities   267,198    (4,768,829)
           
CASH FLOWS FROM FINANCING ACTIVITIES          
Proceeds from issuance of common stock for cash   -    4,195,000 
Proceeds from notes payable   -    925,000 
Payments of notes payable - related parties   (298,834)   (15,386)
Payments of notes payable   (302,168)   (1,698,485)
Net cash provided by financing activities   (601,002)   3,406,129 
           
Effect of exchange rate fluctuations on cash and cash equivalents   (17,996)   67,357 
           
NET DECREASE IN CASH AND RESTRICTED CASH   (351,800)   (1,295,343)
           
CASH AND RESTRICTED CASH - BEGINNING OF PERIOD   202,095    665,002 
           
CASH AND RESTRICTED CASH - END OF PERIOD  $(149,705)  $(630,341)
           
CASH PAID DURING THE PERIOD FOR:          
Interest expense  $-   $- 
           
Income taxes  $-   $- 
           
SUPPLEMENTAL INFORMATION - NON-CASH INVESTING AND FINANCING ACTIVITIES:          
           
Conversion of convertible notes payable and accrued interest to common stock  $-   $14,046,300 
Shares issued for contingent consideration  $-   $915,545 
Shares issued for settlement of accounts payable  $270,000   $- 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

F-4
 

 

CONNEXA SPORTS TECHNOLOGIES INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Note 1: ORGANIZATION AND NATURE OF BUSINESS

 

Organization

 

Lazex Inc. (“Lazex”) was incorporated under the laws of the State of Nevada on July 12, 2015. On August 23, 2019, the majority owner of Lazex entered into a Stock Purchase Agreement with Slinger Bag Americas Inc., a Delaware corporation (“Slinger Bag Americas”), which was 100% owned by Slinger Bag Ltd. (“SBL”), an Israeli company. In connection with the Stock Purchase Agreement, Slinger Bag Americas acquired 50,000 shares of common stock of Lazex for $332,239. On September 16, 2019, SBL transferred its ownership of Slinger Bag Americas to Lazex in exchange for the 50,000 shares of Lazex acquired on August 23, 2019. As a result of these transactions, Lazex owned 100% of Slinger Bag Americas and the sole shareholder of SBL owned 50,000 shares of common stock (approximately 82%) of Lazex. Effective September 13, 2019, Lazex changed its name to Slinger Bag Inc.

 

On October 31, 2019, Slinger Bag Americas acquired control of Slinger Bag Canada, Inc., (“Slinger Bag Canada”) a Canadian company incorporated on November 3, 2017. There were no assets, liabilities or historical operational activity of Slinger Bag Canada.

 

On February 10, 2020, Slinger Bag Americas became the 100% owner of SBL, along with SBL’s wholly owned subsidiary Slinger Bag International (UK) Limited (“Slinger Bag UK”), which was formed on April 3, 2019. On February 10, 2020, the owner of SBL, contributed Slinger Bag UK to Slinger Bag Americas for no consideration.

 

On June 21, 2021, Slinger Bag Americas entered into a membership interest purchase agreement with Charles Ruddy to acquire a 100% ownership stake in Foundation Sports Systems, LLC (“Foundation Sports”). On December 5, 2022, the Company sold 75% of Foundation Sports back to the original sellers. As a result, at that time, the Company recorded a loss on the sale and deconsolidated Foundation Sports.

 

On February 2, 2022, the Company entered into a share purchase agreement with Flixsense Pty, Ltd. (“Gameface”). As a result of the share purchase agreement, Gameface would become a wholly owned subsidiary of the Company.

 

On February 22, 2022, the Company entered into a merger agreement with PlaySight Interactive Ltd. (“PlaySight”) and Rohit Krishnan (the “Shareholders’ Representative”). As a result of the merger agreement, PlaySight would become a wholly owned subsidiary of the Company. In November 2022, the Company sold PlaySight and recorded a loss on the sale.

 

On May 16, 2022, the Company changed its domicile from Nevada to Delaware. On April 7, 2022, the Company effected a name change to Connexa Sports Technologies Inc. We also changed our ticker symbol, “CNXA”.

 

On June 14, 2022, the Company effected a 1-for-10 reverse stock split, where the Company’s common stock began to trade on a reverse split adjusted basis. No fractional shares were issued in connection with the reverse stock split and all such fractional interests were rounded up to the nearest whole number of shares of common stock. All references to the outstanding stock have been retrospectively adjusted to reflect this reverse split. The Company also consummated a public offering of shares of its common stock and the listing of its common stock on the Nasdaq Capital Market.

 

F-5
 

 

On October 10, 2022, the Company received a letter from the Listing Qualifications Department of the Nasdaq indicating that the Company’s common stock is subject to potential delisting from Nasdaq because, for a period of 30 consecutive business days, the bid price of the Company’s common stock has closed below the minimum $1.00 per share requirement for continued listing under Nasdaq Listing Rule 5450(a)(1) (the “Bid Price Rule”). The Nasdaq notice indicated that, in accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company would be provided 180 calendar days, or until April 10, 2023, to regain compliance. If the Company were to fail to regain compliance with the Bid Price Rule before April 10, 2023, the Company may be eligible for an additional 180-calendar day compliance period. The Company failed to regain compliance with the Bid Price Rule by April 10, 2023 and requested and received an additional period of 180 days until October 9, 2023 to regain compliance with the Minimum Bid Price Requirement. On September 13, 2023, the Company obtained shareholder consent to effect a reverse split of its shares of common stock. On September 22, 2023, the Company effected a 1-for-40 reverse stock split, where the Company’s common stock began to trade on a reverse split adjusted basis commencing with trading on September 25, 2023. No fractional shares were issued in connection with the reverse stock split and all such fractional interests were rounded up to the nearest whole number of shares of common stock. All references herein to the outstanding stock have been retrospectively adjusted to reflect this reverse split. In order to regain compliance with the Bid Price Rule by October 9, 2023, the Company’s shares of common stock must trade above $1.00 for 10 consecutive trading days, which means that the Company’s shares must remain above $1.00 through the close of the Nasdaq on Friday, October 9, 2023 in order to regain compliance with the Bid Price Rule.

 

On July 26, 2023, the Company received a letter from the Listing Qualifications Department of Nasdaq indicating that the Company’s stockholders’ equity as reported in its Quarterly Report on Form 10-Q for the quarterly period ended January 31, 2023 did not satisfy the continued listing requirement under Nasdaq Listing Rule 5550(b)(1), which requires that a listed company’s stockholders’ equity be at least $2.5 million (the “Minimum Stockholders’ Equity Requirement”). In addition, the Company did not meet the alternatives of listed securities or net income from continuing operations as of the date of the letter. The Company timely submitted a compliance plan to the Panel and on August 23, 2023 received notice from Nasdaq that it has until January 22, 2024 to demonstrate compliance with the Minimum Stockholders’ Equity Requirement.

 

There can be no assurance that the Company will be able to satisfy the Nasdaq’s continued listing requirements, regain compliance with the Rule, the Minimum Stockholders’ Equity Requirement, and the Minimum Bid Price Requirement, and maintain compliance with other Nasdaq listing requirements.

 

For further details on PlaySight and Foundation Sports we refer you to our Annual Report on Form 10-K for the year ended April 30, 2023, filed with the Securities and Exchange Commission on September 14, 2023. This Form 10-K and the consolidated financial statements will concentrate on our existing business as reflected in the following paragraph.

 

The Company operates in the sport equipment and technology business. The Company is the owner of the Slinger Launcher, which is a portable tennis ball launcher as well as other associated tennis accessories and Gameface AI an Australian artificial intelligence sports software company.

 

The operations of Slinger Bag Inc., Slinger Bag Americas, Slinger Bag Canada, Slinger Bag UK, SBL, and Gameface are collectively referred to as the “Company.”

 

Basis of Presentation

 

The accompanying condensed consolidated financial statements of the Company are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”). As a result of the transactions described above, the accompanying consolidated financial statements include the combined results of Slinger Bag Inc., Slinger Bag Americas, Slinger Bag Canada, Slinger Bag UK, SBL, and Gameface for the periods ended July 31, 2023 and 2022. The operations of Foundation Sports and PlaySight are included as discontinued operations in our statements of operations as these entities were sold in November 2022 and December 2022 for the period ended July 31, 2022.

 

Impact of COVID-19 Pandemic

 

The Company continues to carefully monitor the global COVID-19 pandemic status and its impact on its business. In that regard, while the Company has continued to sell its products it has previously experienced certain minor disruptions in its supply chains. The Company expects the significance of the COVID-19 pandemic, including the extent of its effect on the Company’s financial and operational results, to be dictated by, among other things, the on-going global efforts to contain it. While the Company has not experienced any material disruptions to its business and operations as a result of the COVID-19 pandemic, it is possible such disruptions may occur in the future which may impact its financial and operational results, and which could be material.

 

F-6
 

 

Impact of Russian and Ukrainian Conflict

 

In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. We are closely monitoring the unfolding events due to the Russia-Ukraine conflict and its regional and global ramifications. We have one distributor in Russia, which is not material to our overall financial results. We do not currently have operations in Ukraine or Belarus. We are monitoring any broader economic impact from the current crisis. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these financial statements. However, to the extent that such military action spreads to other countries, intensifies, or otherwise remains active, such action could have a material adverse effect on our financial condition, results of operations, and cash flows.

 

Note 2: GOING CONCERN

 

The financial statements have been prepared on a going concern basis, which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company has an accumulated deficit of $152,597,375 as of July 31, 2023, and more losses are anticipated in the development of the business. Accordingly, there is substantial doubt about the Company’s ability to continue as a going concern. These financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or being able to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they become due. Management intends to finance operating costs over the next twelve months with existing cash on hand, loans from related parties, and/or private placement of debt and/or common stock. In the event that the Company is unable to successfully raise capital and/or generate revenues, the Company will likely reduce general and administrative expenses, and cease or delay its development plan until it is able to obtain sufficient financing. The Company has begun reducing operating expenses and cash outflows by selling PlaySight, as well as selling 75% of Foundation Sports in November and December 2022, respectively to the former shareholders of those companies. There can be no assurance that additional funds will be available on terms acceptable to the Company, or at all. We have recorded the 25% investment in Foundation Sprots at $0.

 

Note 3: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Interim Financial Statements

 

The accompanying condensed financial statements of the Company have been prepared without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and disclosures required by accounting principles generally accepted in the United States have been condensed or omitted pursuant to such rules and regulations. These condensed financial statements reflect all adjustments that, in the opinion of management, are necessary to present fairly the results of operations of the Company for the period presented. The results of operations for the three months ended July 31, 2023, are not necessarily indicative of the results that may be expected for any future period or the fiscal year ending April 30, 2024 and should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended April 30, 2023, filed with the Securities and Exchange Commission on September 14, 2023.

 

Use of Estimates

 

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Accordingly, actual results could differ from those estimates.

 

Financial Statement Reclassification

 

Certain prior year amounts within accounts payable, accrued expenses, and certain operating expenses have been reclassified for consistency with the current year presentation and had no effect on the Company’s balance sheet, net loss, shareholders’ deficit or cash flows.

 

F-7
 

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. The majority of payments due from banks for credit card transactions process within 24 to 48 hours and are accordingly classified as cash and cash equivalents.

 

Accounts Receivable

 

The Company’s accounts receivable are non-interest bearing trade receivables resulting from the sale of products and payable over terms ranging from 15 to 60 days. The Company provides an allowance for doubtful accounts at the point when collection is considered doubtful. Once all collection efforts have been exhausted, the Company charges-off the receivable with the allowance for doubtful accounts. The Company recorded $200,000 and $209,690 in allowance for doubtful accounts as of July 31, 2023 and April 30, 2023, respectively.

 

Inventory

 

Inventory is valued at the lower of the cost (determined principally on a first-in, first-out basis) or net realizable value. The Company’s valuation of inventory includes inventory reserves for inventory that will be sold below cost and the impact of inventory shrink. Inventory reserves are based on historical information and assumptions about future demand and inventory shrink trends. The Company’s inventory as of July 31, 2023 and April 30, 2023 consisted of the following:

 

 

   July 31, 2023   April 30, 2023 
Finished Goods  $400,598   $1,509,985 
Component/Replacement Parts   2,064,041    1,712,553 
Capitalized Duty/Freight   47,279    517,228 
Inventory Reserve   (175,000)   (550,000)
Total  $2,336,918   $3,189,766 

 

Prepaid Inventory

 

Prepaid inventory represents inventory that is in-transit that has been paid for but not received from the Company’s third-party vendors. The Company typically prepays for the purchase of materials and receives the products within three months after making payments. The Company continuously monitors delivery from, and payments to, the vendors. If the Company has difficulty receiving products from a vendor, the Company would cease purchasing products from such vendors in future periods. The Company has not had difficulty receiving products during the reporting periods.

 

Property and equipment

 

Property and equipment acquired through business combinations are stated at the estimated fair value at the date of the acquisition. Purchases of property and equipment are stated at cost, net of accumulated depreciation and impairment losses. Expenditures that materially increase the useful life of the assets are capitalized. Ordinary repairs and maintenance are expensed as incurred. Depreciation and amortization are computed using the straight-line method over the estimated useful lives of the related assets, which is an average of 5 years.

 

Concentration of Credit Risk

 

The Company maintains its cash in bank deposit accounts, the balances of which at times may exceed insured limits. The Company continually monitors its banking relationships and consequently has not experienced any losses in such accounts. While we may be exposed to credit risk, we consider the risk remote and do not expect that any such risk would result in a significant effect on our results of operations or financial condition. See Note 4 for further details on the Company’s concentration of credit risk as well as other risks and uncertainties.

 

F-8
 

 

Revenue Recognition

 

The Company recognizes revenue for their continuing operations in accordance with Accounting Standards Codification (“ASC”) 606, the core principle of which is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to receive in exchange for those goods or services. The Company recognizes revenue for its performance obligation associated with its contracts with customers at a point in time once products are shipped. Amounts collected from customers in advance of shipping products ordered are reflected as contract liabilities on the accompanying consolidated balance sheets. The Company’s standard terms are non-cancelable and do not provide for the right-of-return, other than for defective merchandise covered under the Company’s standard warranty. The Company has not historically experienced any significant returns or warranty issues.

 

The Company recognizes revenue under ASC 606, “Revenue from Contracts with Customers”. The core principle of this revenue standard is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. The following five steps are applied to achieve that core principle:

 

Step 1: Identify the contract with the customer

 

The Company determines that it has a contract with a customer when each party’s rights regarding the products or services to be transferred can be identified, the payment terms for the services can be identified, the Company has determined the customer has the ability and intent to pay, and the contract has commercial substance. At contract inception, the Company evaluates whether two or more contracts should be combined and accounted for as a single contract and whether the combined or single contract includes more than one performance obligation.

 

Step 2: Identify the performance obligations in the contract

 

The Company’s customers are buying an integrated system. In evaluating whether the equipment is a separate performance obligation, the Company’s management considered the customer’s ability to benefit from the equipment on its own or together with other readily available resources and if so, whether the service and equipment are separately identifiable (i.e., is the service highly dependent on, or highly interrelated with the equipment). Because the Products and Services included in the customer’s contract are integrated and highly interdependent, and because they must work together to deliver the Solution, the Company has concluded that Products installed on customer’s premise and Services contracted for by the customer are generally not distinct within the context of the contract and, therefore, constitute a single, combined performance obligation.

 

Step 3: Determine the transaction price

 

The transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer. The consideration promised in a contract with a customer includes predetermined fixed amounts, variable amounts, or both. The Company’s contracts do not include any rights of returns or refunds.

 

The Company collects each year’s service fees in advance and should therefore consider the existence of a significant financing component. However, due to the fact that the payments are provided for the service of a one-year term, the Company elected to apply the practical expedient under ASC 606 which exempts the adjustment of the consideration for the existence of a significant financing component when the period between the transfer of the services and the payment for such services is one year or less.

 

Step 4: Allocate the transaction price to the performance obligations in the contract

 

Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on each performance obligation’s relative standalone selling price (“SSP”). The Company has identified a single performance obligation in the contract, and therefore, the allocation provisions under ASC 606 do not apply to the Company’s contracts.

 

F-9
 

 

Step 5: Recognize revenue when the Company satisfies a performance obligation

 

Revenues for the Company’s single, combined performance obligation are recognized on a straight-line basis over the customer’s contract term, which is the period in which the parties to the contract have enforceable rights and obligations (Typically 3-4 years).

 

Business Combinations

 

Upon acquisition of a company, we determine if the transaction is a business combination, which is accounted for using the acquisition method of accounting. Under the acquisition method, once control is obtained of a business, the assets acquired, and liabilities assumed, are recorded at fair value. We use our best estimates and assumptions to assign fair value to the tangible and intangible assets acquired and liabilities assumed at the acquisition date. One of the most significant estimates relates to the determination of the fair value of these assets and liabilities. The determination of the fair values is based on estimates and judgments made by management. Our estimates of fair value are based upon assumptions we believe to be reasonable, but which are inherently uncertain and unpredictable. Measurement period adjustments are reflected at the time identified, up through the conclusion of the measurement period, which is the time at which all information for determination of the values of assets acquired and liabilities assumed is received and is not to exceed one year from the acquisition date. We may record adjustments to the fair value of these tangible and intangible assets acquired and liabilities assumed, with the corresponding offset to goodwill. The Company elected to apply pushdown accounting to all entities acquired.

 

Additionally, uncertain tax positions and tax-related valuation allowances are initially recorded in connection with a business combination as of the acquisition date. We continue to collect information and reevaluate these estimates and assumptions periodically and record any adjustments to preliminary estimates to goodwill, provided we are within the measurement period. If outside of the measurement period, any subsequent adjustments are recorded to the consolidated statement of operations.

 

Fair Value of Financial Instruments

 

Fair value of financial and non-financial assets and liabilities is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The three-tier hierarchy for inputs used in measuring fair value, which prioritizes the inputs used in the methodologies of measuring fair value for assets and liabilities, is as follows:

 

Level 1 — Quoted prices in active markets for identical assets or liabilities

 

Level 2 — Observable inputs other than quoted prices in active markets for identical assets and liabilities

 

Level 3 — Unobservable pricing inputs in the market

 

Financial assets and financial liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurements. Our assessment of the significance of a particular input to the fair value measurements requires judgment and may affect the valuation of the assets and liabilities being measured and their categorization within the fair value hierarchy.

 

The Company’s financial instruments consist of cash and cash equivalents, accounts receivable, and accounts payable. The carrying amount of these financial instruments approximates fair value due to their short-term maturity.

 

The Company’s contingent consideration in connection with the acquisition of Gameface was calculated using Level 3 inputs. The fair value of contingent consideration as of July 31, 2023 and April 30, 2023 was $418,455 and $418,455, respectively.

 

The Company estimates the fair value of its intangible assets using Level 3 assumptions, primarily based on the income approach utilizing the discounted cash flow method.

 

F-10
 

 

The Company’s derivative liabilities were calculated using Level 2 assumptions on the issuance and balance sheet dates via a Black-Scholes option pricing model and consisted of the following ending balances and gain amounts as of and for the three months ended July 31, 2023:

 

Note derivative is related to 

July 31, 2023

ending balance

  

(Gain) loss for the

three months ended

July 31, 2023

 
4/11/21 profit guaranty  $1,456,854   $- 
8/6/21 convertible notes   74,958    (26,966)
6/17/22 underwriter warrants   4,966    (1,565)
9/30/22 warrants issued with common stock   4,668,608    (1,440,951)
1/6/2023 warrants issued with note payable   2,139,666    (675,072)
Total  $8,345,052   $(2,144,554)

 

The Black-Scholes option pricing model assumptions for the derivative liabilities during the periods ended July 31, 2023 and 2022 consisted of the following:

 

  

Period Ended

July 31, 2023

   

Period Ended

July 31, 2022

 
Expected life in years   0.7-10 years     4-4.3 years 
Stock price volatility   150%    50-148%
Risk free interest rate   4.08%-5.37%    2.90%-3.27%
Expected dividends   0%    0%

 

Income Taxes

 

Income taxes are accounted for in accordance with the provisions of ASC 740, Accounting for Income Taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amounts that are more likely than not to be realized.

 

Intangible Assets

 

Intangible assets relate to the “Slinger” technology trademark, which the Company purchased on November 10, 2020. The Company also acquired intangible assets as a part of the Gameface acquisition. These intangible assets include tradenames, internally developed software, and customer relationships. The acquired intangible assets are amortized based on the estimated present value of cash flows of each class of intangible assets in order to determine their economic useful life. During the three months ended July 31, 2023, the Company impaired their intangible assets down to a nominal value of $1,000 as the technology has changed and Management determined the value to be greater than the fair value of those assets. Refer to Note 5 for more information.

 

Impairment of Long-Lived Assets

 

In accordance with ASC 360-10, the Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that their net book value may not be recoverable. Factors which could trigger impairment review include significant underperformance relative to historical or projected future operating results, significant changes in the manner of use of the assets or the strategy for the overall business, a significant decrease in the market value of the assets or significant negative industry or economic trends. When such factors and circumstances exist, the Company compares the projected undiscounted future cash flows associated with the related asset or group of assets over their estimated useful lives against their respective carrying amount. If those net undiscounted cash flows do not exceed the carrying amount, impairment, if any, is based on the excess of the carrying amount over the fair value based on the market value or discounted expected cash flows of those assets and is recorded in the period in which the determination is made. The Company impaired $100,281 in intangible assets and $14,791 in fixed assets during the three months ended July 31, 2023. Refer to Note 5 for more information.

 

F-11
 

 

Goodwill

 

The Company accounts for goodwill in accordance with ASC 350, Intangibles - Goodwill and Other (“ASC 350”). ASC 350 requires that goodwill not be amortized, but reviewed for impairment if impairment indicators arise and, at a minimum, annually. The Company records goodwill as the excess purchase price over assets acquired and includes any work force acquired as goodwill. Goodwill is evaluated for impairment on an annual basis.

 

With the adoption of the ASU 2017-04, which eliminates the second step of the goodwill impairment test, the Company tests impairment of goodwill in one step. In this step, the Company compares the fair value of each reporting unit with goodwill to its carrying value. The Company determines the fair value of its reporting units with goodwill using a combination of a discounted cash flow and a market value approach. If the carrying value of the net assets assigned to the reporting unit exceeds the fair value of the reporting unit, the Company will record an impairment charge based on the excess of a reporting unit’s carrying amount over its fair value. If the fair value of the reporting unit exceeds the carrying value of the net assets assigned to that reporting unit, goodwill is not impaired and the Company will not record an impairment charge.

 

The Company impaired all goodwill as of April 30, 2023.

 

Share-Based Payment

 

The Company accounts for share-based compensation in accordance with ASC 718, Compensation-Stock Compensation (ASC 718). Under the fair value recognition provisions of this topic, stock-based compensation cost is measured at the grant date based on the fair value of the award and is recognized as an expense on a straight-line basis over the requisite service period, which is the vesting period.

 

Warrants

 

The Company grants warrants to key employees and executives as compensation on a discretionary basis. The Company also grants warrants in connection with certain note payable agreements and other key arrangements. The Company is required to estimate the fair value of share-based awards on the measurement date and recognize as expense that value of the portion of the award that is ultimately expected to vest over the requisite service period. Warrants granted in connection with ongoing arrangements are more fully described in Note 11.

 

The warrants granted during the periods ended July 31, 2023 and 2022 were valued using a Black-Scholes option pricing model on the date of grant using the following assumptions:

 

  

Period Ended

July 31, 2023

  

Period Ended

July 31, 2022

 
Expected life in years     -    510 years 
Stock price volatility   -%   50% - 148%
Risk free interest rate   -%   2.50% - 3.50%
Expected dividends   -%   0%

 

Foreign Currency Translation

 

Our functional currency is the U.S. dollar. The functional currency of our foreign operations, generally, is the respective local currency for each foreign subsidiary. Assets and liabilities of foreign operations denominated in local currencies are translated at the spot rate in effect at the applicable reporting date. Our consolidated statements of comprehensive loss are translated at the weighted average rate of exchange during the applicable period. The resulting unrealized cumulative translation adjustment is recorded as a component of accumulated other comprehensive loss in shareholders’ equity. Realized and unrealized transaction gains and losses generated by transactions denominated in a currency different from the functional currency of the applicable entity are recorded in other income (loss) in the period in which they occur.

 

F-12
 

 

Earnings Per Share

 

Basic earnings per share are calculated by dividing income available to shareholders by the weighted-average number of common shares outstanding during each period. Diluted earnings per share are computed using the weighted average number of common and dilutive common share equivalents outstanding during the period.

 

All common stock equivalents such as shares to be issued for the conversion of notes payable and warrants were excluded from the calculation of diluted earnings per share as the effect is antidilutive. As a result, the basic and diluted earnings per share are the same for each of the periods presented.

 

Recent Accounting Pronouncements

 

Recently Adopted

 

In January 2017, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2017-04, Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment (“ASU 2017-04”), which simplifies how an entity is required to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test. Under ASU 2017-04, goodwill impairment will be tested by comparing the fair value of a reporting unit with its carrying amount, and recognizing an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. The new guidance must be applied on a prospective basis and is effective for periods beginning after December 15, 2022, with early adoption permitted. The Company adopted ASU 2017-04 effective May 1, 2021. The adoption of the new standard did not have a material effect on the Company’s consolidated financial statements.

 

In December 2019, the FASB issued Accounting Standards Update (“ASU”), 2019-12, Simplifying the Accounting for Income Taxes, which amends ASC 740, Income Taxes (ASC 740). This update is intended to simplify accounting for income taxes by removing certain exceptions to the general principles in ASC 740 and amending existing guidance to improve consistent application of ASC 740. This update is effective for fiscal years beginning after December 15, 2021. The guidance in this update has various elements, some of which are applied on a prospective basis and others on a retrospective basis with earlier application permitted. The adoption of the new standard did not have a material effect on the Company’s consolidated financial statements.

 

In August 2020, the FASB issued ASU No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. ASU 2020-06 will simplify the accounting for convertible instruments by reducing the number of accounting models for convertible debt instruments and convertible preferred stock. Limiting the accounting models results in fewer embedded conversion features being separately recognized from the host contract as compared with current GAAP. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting and (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. ASU 2020-06 also amends the guidance for the derivatives scope exception for contracts in an entity’s own equity to reduce form-over-substance-based accounting conclusions. ASU 2020-06 will be effective for public companies for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company is currently evaluating the impact that the adoption of ASU 2020-06 will have on the Company’s consolidated financial statement presentation or disclosures.

 

F-13
 

 

In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASC 326”). The guidance replaces the incurred loss methodology with an expected loss methodology that is referred to as the current expected credit loss (“CECL”) methodology. The measurement of expected credit losses under the CECL methodology is applicable to financial assets measured at amortized cost, including loan receivables and held-to-maturity debt securities. It also applies to off-balance sheet credit exposures not accounted for as insurance (loan commitments, standby letters of credits, financial guarantees, and other similar instruments) and net investments in leases recognized by a lessor in accordance with Topic 842 on leases. ASC 326 requires enhanced disclosures related to the significant estimates and judgments used in estimating credit losses as well as the credit quality and underwriting standards of a company’s portfolio. In addition, ASC 326 made changes to the accounting for available-for-sale debt securities. One such change is to require credit losses to be presented as an allowance rather than as a write-down on available-for-sale debt securities the Company does not intend to sell or believes that it is more likely than not they will be required to sell. The ASU can be adopted no later than January 1, 2020 for SEC filers and January 1, 2023 for private companies and smaller reporting companies. The adoption of the new standard did not have a material effect on the Company’s consolidated financial statements.

 

In October 2021, the FASB issued ASU 2021-08, “Business Combinations - Accounting for Contract Assets and Contract Liabilities (Topic 805)”. The amendments in this Update address diversity and inconsistency related to the recognition and measurement of contract assets and contract liabilities acquired in a business combination. The amendments in this Update require that an acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606, Revenue from Contracts with Customers. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. The adoption of the new standard did not have a material effect on the Company’s consolidated financial statements.

 

The FASB has issued ASU 2021-04, Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic 470-50), Compensation—Stock Compensation (Topic 718), and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40). ASU 2021-04 provides guidance that an entity should treat a modification of the terms or conditions or an exchange of a freestanding equity-classified written call option that remains equity classified after modification or exchange as an exchange of the original instrument for a new instrument. The standard also provides guidance on how an entity should measure and recognize the effect of a modification or an exchange of a freestanding equity-classified written call option that remains equity classified. The amendments in this ASU are effective for the Company for fiscal years beginning after December 15, 2021. Early adoption is permitted for all entities, including adoption in an interim period. The adoption of the new standard did not have a material effect on the Company’s consolidated financial statements.

 

Other recently issued accounting pronouncements did not, or are not believed by management to, have a material effect on the Company’s present or future consolidated financial statements.

 

Note 4: CONCENTRATION OF CREDIT RISK AND OTHER RISKS AND UNCERTAINTIES

 

Accounts Receivable Concentration

 

As of July 31, 2023 and April 30, 2023, the Company had two customers that accounted for 50% and 47% of the Company’s trade receivables balance, respectively.

 

Accounts Payable Concentration

 

As of July 31, 2023 and April 30, 2023, the Company had four significant suppliers that accounted for 60%, and 59% of the Company’s trade payables balances, respectively.

 

Note 5: INTANGIBLE ASSETS

 

Intangible assets reflect only those intangible assets of our continuing operations, and consist of the following:

   (in years)   Value   Amortization   Loss   Value 
   Weighted     
   Average Period   July 31, 2023 
  

Amortization

(in years)

  

Carrying

Value

  

Accumulated

Amortization

  

Impairment

Loss

  

Net Carrying

Value

 
Tradenames and patents   15.26   $385,582   $24,031   $360,551   $1,000 
Customer relationships   9.92    3,930,000    50,038    3,879,962    - 
Internally developed software   4.91    580,000    79,608    500,392    - 
Total intangible assets       $4,895,582   $153,677   $4,740,905   $1,000 

 

F-14
 

 

   (in years)   Value   Amortization   Loss   Value 
   Weighted     
   Average Period   April 30, 2023 
  

Amortization

(in years)

  

Carrying

Value

  

Accumulated

Amortization

  

Impairment

Loss

  

Net Carrying

Value

 
Tradenames and patents   15.26   $385,582   $24,031    260,270   $101,281 
Customer relationships   9.92    3,930,000    50,038    3,879,962    - 
Internally developed software   4.91    580,000    79,608    500,392    - 
Total intangible assets       $4,895,582   $153,677   $4,640,624   $101,281 

 

Amortization expense for the three months ended July 31, 2023 and 2022 was approximately $0 and $1,445, respectively. The Company impaired $100,281 in the three months ended July 31, 2023. The remaining $1,000 is a nominal value related to the Company’s patents. This amount is not expected to be amortized any further.

 

Note 6: ACCRUED EXPENSES

 

The composition of accrued expenses is summarized below:

   July 31, 2023   April 30, 2023 
Accrued payroll  $1,754,936   $1,535,186 
Accrued bonus   1,829,604    1,720,606 
Accrued professional fees   35,000    490,424 
Other accrued expenses   1,577,920    1,165,623 
Total  $5,197,460   $4,911,839 

 

Note 7: NOTE PAYABLE - RELATED PARTY

 

The discussion of note payable – related party only includes those that existed as of April 30, 2023. For a discussion of all prior note payable – related party we refer you to the Annual Report on Form 10-K filed September 14, 2023 for the fiscal year end April 30, 2023.

 

On January 14, 2022, the Company entered into two loan agreements with related party lenders, each for $1,000,000, pursuant to which the Company received a total amount of $2,000,000. The loans bear interest at a rate of 8% per annum and are required to be repaid in full by April 30, 2022 or such other date as may be accepted by the lenders. The Company is not permitted to make any distribution or pay any dividends unless or until the loans are repaid in full. On June 28, 2022, the Company entered into amendments for the two related party loan agreements with the lenders in which the repayment date was extended to July 31, 2024.

 

There was $1,655,966 and $1,953,842 in outstanding borrowings from related parties as of July 31, 2023 and April 30, 2023. Interest expense related to the related parties for the three months ended July 31, 2023 and 2022 amounted to $0 and $61,121, respectively. Accrued interest due to related parties as of July 31, 2023 and April 30, 2023 amounted to $917,957 and $917,957, respectively. The accrued interest includes notes that were either repaid or converted but the interest remained.

 

On January 6, 2023, we sold certain of our inventory including all components, parts, additions and accessions thereto to Yonah Kalfa and Naftali Kalfa who immediately consigned it back to us in exchange for a payment of $103 per ball launcher we sell until we have paid them an aggregate total of $2,092,700, which represents payment in full of the principal amounts of and accrued interest in respect of the Loan Agreements (as defined above) and certain other expenses they incurred in connection with the Company.

 

F-15
 

 

Note 8: CONVERTIBLE NOTES PAYABLE

 

The discussion of convertible notes payable only includes those that existed as of April 30, 2023. For a discussion of all prior convertible notes payable we refer you to the Annual Report on Form 10-K filed September 14, 2023 for the fiscal year end April 30, 2023.

 

As of April 30, 2023, all outstanding convertible notes payable had been fully converted into outstanding common shares. On June 17, 2022, the Company issued 109,737 shares of common stock in conversion of the $13,200,000 in convertible notes payable and $846,301 in accrued interest. In addition, the remaining $122,222 of unamortized discount on the convertible notes payable was amortized and included in our consolidated statements of operations for the three months ended July 31, 2022.

 

Note 9: NOTES PAYABLE

 

The discussion of notes payable only includes those that existed as of April 30, 2023. For a discussion of all prior notes payable we refer you to the Annual Report on Form 10-K filed September 14, 2023 for the fiscal year end April 30, 2023.

 

On April 11, 2021, the Company and the lender entered into an agreement whereby the lender converted the promissory note into 681 shares of Company stock, which were issued to the lender at a 20% discount from the closing price of the stock on the day prior to the conversion. In addition to the discount, the agreement contains a guarantee that the aggregate gross sales of the shares by the lender will be no less than $1,500,000 over the next three years and if the aggregate gross sales are less than $1,500,000 the Company will issue additional shares of common stock to the lender for the difference between the total gross proceeds and $1,500,000, which could result in an infinite number of shares being required to be issued.

 

The Company evaluated the conversion option of the note payable to shares under the guidance in ASC 815-40, Derivatives and Hedging, and determined the conversion option qualified for equity classification. The Company also evaluated the profit guarantee under ASC 815, Derivatives and Hedging, and determined it to be a make-whole provision, which is an embedded derivative within the host instrument. As the economic characteristics are dissimilar to the host instrument, the profit guarantee was bifurcated from the host instrument and stated as a separate derivative liability, which is marked to market at the end of each reporting period with the non-cash gain or loss recorded in the period as a gain or loss on derivative.

 

On the date of conversion, the Company recognized a $1,501,914 loss on extinguishment of debt, which represented the difference between the promissory note and the fair value of the shares issued of $1,250,004, which were recorded in shares issued in connection with conversion of note payable within shareholders’ equity, as well as the derivative liability of $1,251,910, which was valued using a Black-Scholes option pricing model.

 

The fair value of the derivative liability was $1,456,854 and $1,456,854 as of April 30, 2023 and 2022.

 

On February 15, 2022, for and in consideration of $4,000,000 the Company conveyed, sold, transferred, set over, assigned and delivered to Slinger Bag Consignment, LLC, a Virginia limited liability company (“Consignor”), all of the Company’s right, title and interest in and to 13,000 units of certain surplus inventory, including all components, parts, additions and accessions thereto (collectively, the “Consigned Goods”). The Company has repaid the $4,000,000 as of April 30, 2023 ($1,559,109 as of July 31, 2022).

 

On April 1, 2022, the Company entered into a $500,000 note payable. The note was to mature on July 1, 2022 and bears interest at eight percent (8%) per year. The Company pays interest monthly and will pay all accrued and unpaid interest on the maturity date in which the outstanding principal is due. On August 1, 2022, the Company repaid the $500,000.

 

F-16
 

 

Cash Advance Agreements

 

On July 29, 2022, the Company entered into two merchant cash advance agreements. The details of the merchant cash advance agreements are as follows:

 

UFS Agreement

 

The Company entered into an agreement (the “UFS Agreement”) with Unique Funding Solutions LLC (“UFS”) pursuant to which the Company sold $1,124,250 in future receivables (the “UFS Receivables Purchased Amount”) to UFS in exchange for payment to the Company of $750,000 in cash less fees of $60,000. The Company agreed to pay UFS $13,491 each week for the first three weeks and thereafter $44,970 per week until the UFS Receivables Purchased Amount is paid in full.

 

In order to secure payment and performance of the Company’s obligations to UFS under the UFS Agreement, the Company granted to UFS a security interest in the following collateral: all accounts receivable and all proceeds as such term is defined by Article 9 of the UCC. The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to any of such collateral.

 

Cedar Agreement

 

The Company entered into an agreement (the “Cedar Agreement”) with Cedar Advance LLC (“Cedar”) pursuant to which the Company sold $1,124,250 in future receivables (the “Cedar Receivables Purchased Amount”) to Cedar in exchange for payment to the Company of $750,000 in cash less fees of $60,000. The Company agreed to pay Cedar $13,491 each week for the first three weeks and thereafter $44,970 per week until the Cedar Receivables Purchased Amount is paid in full.

 

In order to secure payment and performance of the Company’s obligations to Cedar under the Cedar Agreement, the Company granted to Cedar a security interest in the following collateral: all accounts, including without limitation, all deposit accounts, accounts receivable and other receivables, chattel paper, documents, equipment, instruments and inventory as those terms are defined by Article 9 of the UCC. The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to any of such collateral.

 

On January 6, 2023, the Company entered into a loan and security agreement (the “Loan and Security Agreement”) with one or more institutional investors (the “Lenders”) and Armistice Capital Master Fund Ltd. as agent for the Lenders (the “Agent”) for the issuance and sale of (i) a note in an aggregate principal amount of up to $2,000,000 (the “Note”) with the initial advance under the Loan and Security Agreement being $1,400,000 and (ii) warrants (the “Warrants”) to purchase a number of shares of common stock of the Company equal to 200% of the face amount of the Note divided by the closing price of the common stock of the Company on the date of the issuance of the Notes (collectively, the “Initial Issuance”). The closing price of the Company’s common stock on January 6, 2023, as reported by Nasdaq, was $8.84 per share, so the Warrants in respect of the initial advance under the Note are exercisable for up to 452,489 shares of the Company’s common stock. The Warrants have an exercise price per share equal to the closing price of the common stock of the Company on the date of the issuance of the Note, or $8.84 per share and a term of five- and one-half (5½) years following the initial exercise date. The initial exercise date of the Warrants will be the date stockholder approval is received and effective allowing exercisability of the Warrants under Nasdaq rules. Pursuant to the terms of the Loan and Security Agreement, an additional advance of $600,000 may be made to the Company under the Note. The Company’s obligations under the terms of the Loan and Security Agreement are fully and unconditionally guaranteed by all of the Company’s subsidiaries (the “Guarantors”). The Company measured the warrants granted on January 6, 2023 at $3,715,557, and discounted the note payable to $0 and recorded a derivative expense of $1,715,557.

 

The derivative liability was valued at $2,139,666 and $2,814,738 as of July 31, 2023 and April 30, 2023, respectively. The Company recognized a gain on the change in fair value of the derivative liability when remeasured for the three months ended July 31, 2023 of $675,072. In addition, the Company recognized $777,192 in amortization of debt discount for the three months ended July 31, 2023. On July 6, 2023, the Company failed to repay the note and is currently in default. The interest rate has since increased to 6.43% per annum.

 

F-17
 

 

Meged Agreement

 

On June 8, 2023, the Company entered into a merchant cash advance agreement with Meged Funding Group (“Meged”) pursuant to which the Company sold $315,689 in future receivables to Meged (the “Meged Receivables Purchased Amount”) to in exchange for payment to the Company of $210,600 in cash less fees of $10,580. The Company agreed to pay Meged $17,538 each week until the Meged Receivables Purchased Amount is paid in full.

 

Note 10: RELATED PARTY TRANSACTIONS

 

In support of the Company’s efforts and cash requirements, it may rely on advances from related parties until such time that the Company can support its operations or attain adequate financing through sales of its equity or traditional debt financing. There is no formal written commitment for continued support by officers, directors, or shareholders. Amounts represent advances, amounts paid in satisfaction of liabilities, or accrued compensation that has been deferred. The advances are considered temporary in nature and have not been formalized by a promissory note.

 

The Company has outstanding notes payable of $1,655,966 and $1,953,842 and accrued interest of $917,957 and $917,957 due to a related party as of July 31, 2023 and April 30, 2023, respectively (see Note 7).

 

The Company recognized net sales of $50,900 and $91,200 during the three months ended July 31, 2023 and 2022, respectively, to related parties. As of July 31, 2023 and 2022, related parties had accounts receivable due to the Company of $28,800 and $28,800, respectively.

 

Note 11: SHAREHOLDERS’ EQUITY (DEFICIT)

 

Common Stock

 

The Company has 300,000,000 shares of common stock authorized with a par value of $0.001 per share. As of July 31, 2023 and April 30, 2023, the Company had 528,297 and 338,579 shares of common stock issued and outstanding, respectively.

 

For the period May 1, 2023 through July 31, 2023, the Company issued 189,718 shares of common stock to ambassadors under their agreements (188), to vendors in settlement of accounts payable (67,500), for settlement with former owners of FSS (1,350), for the exercise of warrants (27,000) and to satisfy the profit guarantee on a note (93,680).

 

Equity Transactions During the Year Ended April 30, 2023

 

The Company has issued an aggregate of 151,579 shares of its common stock consisting of the following:

 

    On June 15, 2022, the Company issued 109,737 shares of common stock to the Convertible Noteholders upon conversion of convertible notes.
     
    On June 15, 2022, the Company issued 26,219 shares to investors who participated in the Company’s Nasdaq uplist round.
     
    On June 27, 2022, the Company issued 625 shares of common stock to Gabriel Goldman for consulting services performed in the first quarter of calendar 2022. Gabriel Goldman became a director of the Company on June 15, 2022.
     
    On June 27, 2022, the Company issued 14,960 shares of common stock to the former Gameface shareholders in connection with the purchase of Gameface.

 

F-18
 

 

   

On August 25, 2022, the Company issued 750 shares of common stock to Midcity Capital Ltd (“Midcity”) pursuant to a cashless conversion of warrants Midcity received from its warrant agreement with the Company dated March 2020.

 

On September 28, 2022, the Company entered into a securities purchase agreement (the “Securities Purchase Agreement”) with a single institutional investor (the “Investor”) for the issuance and sale of (i) 25,463 shares of common stock and (ii) pre-funded warrants (the “Pre-Funded Warrants”) to purchase an aggregate of 295,050 shares of its common stock, together with accompanying common stock warrants, at a combined purchase price of $15.60 per share of the common stock and associated common stock warrant and $15.596 per Pre-Funded Warrant and associated common stock warrants for an aggregate amount of approximately $5.0 million (the “Offering”). The Pre-Funded Warrants have an exercise price of $0.0004 per share of common stock and are exercisable until the Pre-Funded Warrants are exercised in full. The shares of common stock and Pre-Funded Warrants were sold in the offering together with common stock warrants to purchase 320,513 shares of common stock at an exercise price of $15.60 per share and a term of five years following the initial exercise date (the “5-Year Warrants”) and 641,026 common stock warrants to purchase 641,026 shares of common stock at an exercise price of $17.20 per share and a term of seven and one half years (the “7.5-Year Warrants”) following the initial exercise date (collectively, the “Warrants”). The Warrants issued in the Offering contain variable pricing features. The Warrants and Pre-Funded Warrants will be exercisable beginning on the date stockholder approval is received and effective allowing exercisability of the Warrants and Pre-Funded Warrants under Nasdaq rules. Net proceeds to the Company were $4,549,882.

 

On October 12, 2022, the Company issued 48,098 shares of common stock, on November 21, 2022 issued 675 shares of common stock and January 26, 2023 issued 6,993 shares of common stock in connection with the acquisition of PlaySight.

 

On January 26, 2023, the Company issued 150 shares of common stock for services rendered to their ambassadors.

 

The Company has not granted any warrants for the three months ended July 31, 2023.

 

Warrants Granted During the Year Ended April 30, 2023

 

On September 28, 2022, the Company entered into a securities purchase agreement (the “Securities Purchase Agreement”) with a single institutional investor (the “Investor”) for the issuance and sale of (i) 25,463 shares of common stock and (ii) pre-funded warrants (the “Pre-Funded Warrants”) to purchase an aggregate of 295,050 shares of its common stock, together with accompanying common stock warrants, at a combined purchase price of $15.60 per share of the common stock and associated common stock warrant and $15.596 per Pre-Funded Warrant and associated common stock warrants for an aggregate amount of approximately $5.0 million (the “Offering”). The Pre-Funded Warrants have an exercise price of $0.0004 per share of common stock and are exercisable until the Pre-Funded Warrants are exercised in full. The shares of common stock and Pre-Funded Warrants were sold in the offering together with common stock warrants to purchase 320,513 shares of common stock at an exercise price of $15.60 per share and a term of five years following the initial exercise date (the “5-Year Warrants”) and 641,026 common stock warrants to purchase 641,026 shares of common stock at an exercise price of $17.20 per share and a term of seven and one half years (the “7.5-Year Warrants”) following the initial exercise date (collectively, the “Warrants”). The Warrants issued in the Offering contain variable pricing features. The Warrants and Pre-Funded Warrants will be exercisable beginning on the date stockholder approval is received and effective allowing exercisability of the Warrants and Pre-Funded Warrants under Nasdaq rules. The exercise price of the Warrants was reset in January 2023 to $8.84 per share.

 

On January 6, 2023, the Company entered into a loan and security agreement (the “Loan and Security Agreement”) with one or more institutional investors (the “Lenders”) and Armistice Capital Master Fund Ltd. as agent for the Lenders (the “Agent”) for the issuance and sale of (i) a note in an aggregate principal amount of up to $2,000,000 (the “Note”) at 4.33% interest per annum unless in default, with the initial advance under the Loan and Security Agreement being $1,400,000 and (ii) warrants (the “Warrants”) to purchase a number of shares of common stock of the Company equal to 200% of the face amount of the Note divided by the closing price of the common stock of the Company on the date of the issuance of the Notes (collectively, the “Initial Issuance”). The closing price of the Company’s common stock on January 6, 2023, as reported by Nasdaq, was $8.84 per share, so the Warrants in respect of the initial advance under the Note are exercisable for up to 452,489 shares of the Company’s common stock. The Warrants have an exercise price per share equal to the closing price of the common stock of the Company on the date of the issuance of the Note, or $8.84 per share and a term of five- and one-half (5½) years following the initial exercise date. The initial exercise date of the Warrants will be the date stockholder approval is received and effective allowing exercisability of the Warrants under Nasdaq rules. Pursuant to the terms of the Loan and Security Agreement, an additional advance of $600,000 may be made to the Company under the Note which occurred on February 2, 2023. The Company’s obligations under the terms of the Loan and Security Agreement are fully and unconditionally guaranteed by all of the Company’s subsidiaries (the “Guarantors”).

 

F-19
 

 

Note 12: COMMITMENTS AND CONTINGENCIES

 

Leases

 

The Company leases office space under short-term leases with terms under a year. Total rent expense for the three months ended July 31, 2023 and 2022 amounted to $1,969 and $700, respectively.

 

Contingencies

 

In connection with the Gameface acquisition on February 2, 2022, the Company agreed to earn-out consideration of common shares of the Company’s common stock with a fair value of $1,334,000.

 

The Company issued 14,960 common shares to the former Gameface shareholders in June 2022. The balance of the contingent consideration as of July 31, 2023 and April 30, 2023 is $418,455.

 

From time to time, the Company may become involved in legal proceedings arising in the ordinary course of business. The Company is not presently a party to any legal proceedings that it currently believes would individually or taken together have a material adverse effect on the Company’s business or financial statements.

 

Nasdaq Compliance

 

On March 21, 2023, the Company received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company’s failure to file its Quarterly Report on Form 10-Q for the period ended January 31, 2023 (“Additional Delinquency”) serves as an additional basis for delisting the Company’s securities from Nasdaq. The Company received a letter from the Nasdaq on February 14, 2023, indicating that, due to the Company’s failure, in violation of Listing Rule 5250(c)(1), to file its (i) Annual Report on Form 10-K with respect to the fiscal year ended April 30, 2022; and (ii) Quarterly Reports on Form 10-Q for the periods ended July 31, 2022 and October 31, 2022 (collectively, the “Delinquent Filings”), by February 13, 2023 (the due date for filing the Delinquent Filings pursuant to an exception to Nasdaq’s Listing Rule previously granted by Nasdaq), absent the submission of a timely appeal by February 21, 2023, trading of the Company’s common stock would have been suspended from the Nasdaq at the opening of business on February 23, 2023. Nasdaq would also have filed a Form 25-NSE with the Securities and Exchange Commission (the “SEC”), which would have resulted in the removal of the Company’s securities from listing and registration on the Nasdaq (the “Staff Determination”). Additionally, on October 10, 2022, the Company received a letter from Nasdaq indicating that the Company’s common stock is subject to potential delisting from Nasdaq because, for a period of 30 consecutive business days, the bid price of the Company’s common stock had closed below the minimum $1.00 per share requirement for continued listing under Nasdaq Listing Rule 5450(a)(1).

 

On January 12, 2023, Nasdaq notified the Company that due to the resignations from the Company’s board, audit committee and compensation committee on November 17, 2022 (“Corporate Governance Deficiencies”), the Company no longer complies with Nasdaq’s independent director, audit committee and compensation committee requirements as set forth in Listing Rule 5605. The Company timely submitted its plan of compliance with respect to the Corporate Governance Deficiencies by February 27, 2023 as required by the Nasdaq. However, pursuant to Listing Rule 5810(c)(2)(A), the Corporate Governance Deficiencies serve as an additional and separate basis for delisting and the Company.

 

F-20
 

 

On February 21, 2023, consistent with the Company’s previously announced intention to request an appeal of the Staff Determination by requesting a hearing before the Nasdaq Hearings Panel (the “Panel”) to stay the suspension of the Company’s securities and the filing of the Form 25-NSE with the SEC (the “Hearing”), the Company appealed the Staff Determination to the Panel, and requested that the stay of delisting, which otherwise would expire on March 8, 2023, pursuant to Listing Rule 5815(a)(1)(B), be extended until the Panel issued a final decision on the matter. The Nasdaq granted the Company’s request to extend the stay, pending the Hearing scheduled for March 30, 2023, and a final determination regarding the Company’s listing status. The Company is required to address the Additional Delinquency, the Delinquent Filings, and the Corporate Governance Deficiencies before the Panel. Although the Company is working diligently to file the Delinquent Filings and Additional Delinquency, there can be no assurance that they will be filed prior to the Hearing. If the Company’s appeal is denied or the Company fails to timely regain compliance with Nasdaq’s continued listing standards, the Company’s common stock will be subject to delisting on the Nasdaq.

 

On March 21, 2023, the Company received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company’s failure to file its Quarterly Report on Form 10-Q for the period ended January 31, 2023 (“Additional Delinquency”) serves as an additional basis for delisting the Company’s securities from Nasdaq. The Company received a letter from the Nasdaq on February 14, 2023, indicating that, due to the Company’s failure, in violation of Listing Rule 5250(c)(1), to file its (i) Annual Report on Form 10-K with respect to the fiscal year ended April 30, 2022; and (ii) Quarterly Reports on Form 10-Q for the periods ended July 31, 2022 and October 31, 2022 (collectively, the “Delinquent Filings”), by February 13, 2023 (the due date for filing the Delinquent Filings pursuant to an exception to Nasdaq’s Listing Rule previously granted by Nasdaq), absent the submission of a timely appeal by February 21, 2023, trading of the Company’s common stock would have been suspended from the Nasdaq at the opening of business on February 23, 2023. Nasdaq would also have filed a Form 25-NSE with the Securities and Exchange Commission (the “SEC”), which would have resulted in the removal of the Company’s securities from listing and registration on the Nasdaq (the “Staff Determination”). Additionally, on October 10, 2022, the Company received a letter from Nasdaq indicating that the Company’s common stock is subject to potential delisting from Nasdaq because, for a period of 30 consecutive business days, the bid price of the Company’s common stock had closed below the minimum $1.00 per share requirement for continued listing under Nasdaq Listing Rule 5450(a)(1).

 

On March 30, 2023, the Company had its hearing with the Nasdaq.

 

On April 12, 2023, Nasdaq notified the Company that the Panel had granted the Company’s request for continued listing on the Nasdaq had been granted subject to the following:

 

1. On or before May 31, 2023, the Company shall file the delinquent Form 10-K for the year ended April 30, 2022, with the SEC;

 

2. On or before June 30, 2023, the Company shall file all delinquent Forms 10-Q with the SEC;

 

3. On or before July 15th, the Company will demonstrate compliance with Listing Rules 5605(b)(1), 5605(c)(2) and 5605(d)(2) (majority independent director, audit committee and compensation committee composition requirements).

 

On April 12, 2023, the Company received a letter from the Listing Qualifications Department of the Nasdaq indicating that the Company had not yet regained compliance with the Bid Price Rule, which serves as an additional basis for delisting the Company’s securities from the Nasdaq. The letter further indicated that the Panel will consider this matter in its decision regarding the Company’s continued listing on the Nasdaq Capital Market. In that regard, the Nasdaq indicated that the Company should present its views with respect to this additional delinquency to the Panel in writing no later than April 19, 2023, which it did.

 

On April 26, 2023, Nasdaq notified the Company that the Panel had granted the Company’s request to regain compliance with the Bid Price Rule by October 9, 2023.

 

On June 29, 2023, the Company received an extension until July 25, 2023 to file their delinquent 10-Q’s for the fiscal year ending April 30, 2023.

 

F-21
 

 

On July 26, 2023, the Company received a letter from the Listing Qualifications Department of Nasdaq indicating that the Company’s stockholders’ equity as reported in its Quarterly Report on Form 10-Q for the quarterly period ended January 31, 2023 did not satisfy the continued listing requirement under Nasdaq Listing Rule 5550(b)(1), which requires that a listed company’s stockholders’ equity be at least $2.5 million (the “Minimum Stockholders’ Equity Requirement”). As reported in its Form 10-Q for the period ended January 31, 2023, the Company’s stockholders’ equity as of January 31, 2023 was approximately $(11.7) million. In addition, the Company did not meet the alternatives of listed securities or net income from continuing operations as of the date of the letter. The Nasdaq has given the Company until January 22, 2024 to regain compliance with the Minimum Stockholders’ Equity Requirement and net income from continuing operations requirement.

 

The Company offers no assurance that it will regain compliance with the Bid Price Rule, the Minimum Stockholders’ Equity Requirement and/or any other delinquency in a timely manner.

 

Note 13: DISCONTINUED OPERATIONS

 

On November 27, 2022, the Company entered into a share purchase agreement (the “Agreement”) with PlaySight, Chen Shachar and Evgeni Khazanov (together, the “Buyer”) pursuant to which the Buyer purchased 100% of the issued and outstanding shares of PlaySight from the Company in exchange for (1) releasing the Company from all of PlaySight’s obligations towards its vendors, employees, tax authorities and any other (past, current and future) creditors of PlaySight; (2) waiver by the Buyer of 100% of the personal consideration owed to them under their employment agreements in the total amount of $600,000; and (3) cash consideration of $2,000,000 to be paid to the Company in the form of a promissory note that matures on December 31, 2023.

 

On December 5, 2022, the Company assigned 75% of its membership interest in Foundation Sports to Charles Ruddy, its founder and granted him the right for a period of three years to purchase the remaining 25% of its Foundation Sports membership interests for $500,000 in cash. As of December 5, 2022, the results of Foundation Sports will no longer be consolidated in the Company’s financial statements, and the investment was accounted for as an equity method investment. On December 5, 2022, the Company analyzed this investment and established a reserve for the investment at the full amount of $500,000.

 

The Company accounted for these sales as a disposal of a business under ASC 205-20-50-1(a). The Company had reclassified the operations of PlaySight and Foundation Sports as discontinued operations as the disposal represents a strategic shift that will have a major effect on the Company’s operations and financial results.

 

The Company reclassified the following operations to discontinued operations for the three months ended July 31, 2023.

  

   2023 
Revenue  $1,363,113 
Operating expenses   3,278,269 
Other (income) loss   (155,442)
Net loss from discontinued operations  $(1,759,714)

 

Note 14: SUBSEQUENT EVENTS

 

From August 1, 2023 through the date hereof, the Company issued the following shares of common stock:

 

On August 1, 2023, the Company issued 31,042 shares of common stock to Armistice upon the exercise of its Pre-Funded Warrants.

 

On August 17, 2023, the Company issued 1,876 shares of common stock to Rodney Rapson as compensation for Mr. Rapson’s advisory services under the advisory agreement between the Company and Mr. Rapson.

 

On August 31, 2023, the Company issued 42,500 shares of common stock to the Lender (as defined below) in connection with the Conversion (as defined below).

 

On September 18, 2023, the Company issued 125,134 shares of common stock to Armistice upon the exercise of its Pre-Funded Warrants.

 

On September 19, 2023, the Company issued 9,444 shares of common stock to Armistice upon the exercise of its Pre-Funded Warrants.

 

F-22
 

 

UFS Agreement

 

On August 7, 2023, the Company entered into an agreement with UFS (the “UFS Agreement”) pursuant to which the Company sold $797,500 in future receivables (the “UFS Second Receivables Purchased Amount”) to UFS in exchange for payment to the Company of $550,000 in cash less fees of $50,000. The Company agreed to pay UFS $30,000 each week until the UFS Second Receivables Purchased Amount is paid in full.

 

In order to secure payment and performance of the Company’s obligations to UFS under the UFS Agreement, the Company granted to UFS a security interest in the following collateral: all accounts receivable and all proceeds as such term is defined by Article 9 of the UCC. The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to any of such collateral.

 

On August 21, 2023, the Company amended its arrangement with MidCity and agreed to issue 42,500 shares of stock monthly for eight months to settle the profit guarantee under its prior note arrangement from April 2020. The parties agreed to a one-time true-up at March 31, 2024 if any further amounts are due MidCity at that time.

 

On September 19, 2023, the Company entered into an agreement with Meged (the “Second Meged Agreement”) pursuant to which the Company sold $423,000 in future receivables to Meged (the “Meged Second Receivable Amount”) in exchange for paying the then outstanding balance of $70,153.20 of the Meged Receivables Purchased Amount in full with the balance being retained by the Company in cash for general purposes. The Company agreed to pay Meged $15,107.14 each week until the Meged Second Receivable Amount is paid in full.

 

In order to secure payment and performance of the Company’s obligations to Meged under the Second Meged Agreement, the Company granted to Meged a security interest in the following collateral: all accounts receivable and all proceeds as such term is defined by Article 9 of the UCC. The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to any of such collateral.

 

F-23
 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following discussion of our financial condition and results of operations should be read in conjunction with the financial statements and related notes included elsewhere in this report and our Annual Report on Form 10-K for the year ended April 30, 2023. Certain statements in this discussion and elsewhere in this report constitute forward-looking statements. See “Cautionary Statement Regarding Forward Looking Information’’ elsewhere in this report. Because this discussion involves risks and uncertainties, our actual results may differ materially from those anticipated in these forward-looking statements.

 

Overview

 

Lazex Inc. (“Lazex”) was incorporated under the laws of the State of Nevada on July 12, 2015. On August 23, 2019, the majority owner of Lazex entered into a Stock Purchase Agreement with Slinger Bag Americas Inc., a Delaware corporation (“Slinger Bag Americas”), which was 100% owned by Slinger Bag Ltd. (“SBL”), an Israeli company. In connection with the Stock Purchase Agreement, Slinger Bag Americas acquired 2,000,000 shares of common stock of Lazex for $332,239. On September 16, 2019, SBL transferred its ownership of Slinger Bag Americas to Lazex in exchange for the 2,000,000 shares of Lazex acquired on August 23, 2019. As a result of these transactions, Lazex owned 100% of Slinger Bag Americas and the sole shareholder of SBL owned 2,000,000 shares of common stock (approximately 82%) of Lazex. Effective September 13, 2019, Lazex changed its name to Slinger Bag Inc.

 

On October 31, 2019, Slinger Bag Americas acquired control of Slinger Bag Canada, Inc., (“Slinger Bag Canada”) a Canadian company incorporated on November 3, 2017. There were no assets, liabilities or historical operational activity of Slinger Bag Canada.

 

On February 10, 2020, Slinger Bag Americas became the 100% owner of SBL, along with SBL’s wholly owned subsidiary Slinger Bag International (UK) Limited (“Slinger Bag UK”), which was formed on April 3, 2019. On February 10, 2021, Zehava Tepler, the owner of SBL, contributed Slinger Bag UK to Slinger Bag Americas for no consideration.

 

Effective February 25, 2020, the Company increased the number of authorized shares of common stock from 75,000,000 to 300,000,000 via a four-to-one forward split of its outstanding shares of common stock. All share and per share information contained in this report have been retroactively adjusted to reflect the impact of the stock split.

 

On June 21, 2021, Slinger Bag Americas entered into a membership interest purchase agreement with Charles Ruddy to acquire a 100% ownership stake in Foundation Sports Systems, LLC (“Foundation Sports”).

 

On February 2, 2022, the Company entered into a share purchase agreement with Flixsense Pty, Ltd. (“Gameface”). As a result of the share purchase agreement, Gameface would become a wholly owned subsidiary of the Company.

 

On February 22, 2022, the Company entered into a merger agreement with PlaySight Interactive Ltd. (“PlaySight”) and Rohit Krishnan (the “Shareholders’ Representative”). As a result of the merger agreement, PlaySight became a wholly owned subsidiary of the Company.

 

On June 14, 2022, the Company effected a 1-for-10 reverse stock split, where the Company’s common stock began to trade on a reverse split adjusted basis. No fractional shares were issued in connection with the reverse stock split and all such fractional interests were rounded up to the nearest whole number of shares of common stock. All references to the outstanding stock have been retrospectively adjusted to reflect this reverse split. The Company also consummated a public offering of shares of its common stock and the listing of its common stock on the Nasdaq Capital Market.

 

On November 17, 2022, Gabriel Goldman and Rohit Krishnan resigned from the board of directors of the Company. Gabriel and Rohit were members of the audit and compensation committees. Gabriel Goldman was a member of the Company’s Nominating and Corporate Governance Committee. Neither Gabriel nor Rohit advised the Company of any disagreement with the Company on any matter relating to its operations, policies or practices.

 

1
 

 

On December 5, 2022, the Company assigned 75% of its membership interest in Foundation Sports to Charles Ruddy, its founder and granted him the right for a period of three years to purchase the remaining 25% of its Foundation Sports membership interests for $500,000 in cash. As of December 5, 2022, the results of Foundation Sports were no longer be consolidated in the Company’s financial statements, the Company recorded a loss on the sale and the investment is now accounted for as an equity method investment. On December 5, 2022, the Company analyzed this investment and established a reserve for the investment at the full amount of $500,000.

 

On November 27, 2022, the Company entered into a share purchase agreement (the “Agreement”) with PlaySight, Chen Shachar and Evgeni Khazanov (together, the “Buyer”) pursuant to which the Buyer purchased 100% of the issued and outstanding shares of PlaySight from the Company in exchange for (1) releasing the Company from all of PlaySight’s obligations towards its vendors, employees, tax authorities and any other (past, current and future) creditors of PlaySight; (2) waiver by the Buyer of 100% of the personal consideration owed to them under their employment agreements in the total amount of U.S. $600,000 (which would have been increased in December 2022 to U.S. $800,000); and (3) cash consideration of U.S. $2 million to be paid to the Company as follows:

 

  (i) a promissory note in the amount of U.S. $2 million issued and delivered to the Company (the “Promissory Note”).
     
  (ii) The maturity due date of the Promissory Note is December 31, 2023 subject to a one year extension in the discretion of the Buyer until December 31, 2024.
     
  (iii) The Promissory Note can be partially paid over the time, but in the event it is not paid in full by December 31, 2024, then the remaining amount due (i.e. U.S. $2 million less any amount paid), will be converted into ordinary shares of PlaySight (the “Deposited Shares”), which will be deposited with the escrow company of Altshuler Shaham Trust Ltd. (the “Escrow Agent”) for the benefit of the Company or, at the election of the Company, issued in the form of a stock certificate or recorded in some other market-standard format to be held by the Escrow Agent.
     
  (iv) The number of the Deposited Shares shall be determined according to the post-money valuation of the last investment round of the Company, and in the absence of such investment round, the total number of the Deposited Shares shall be $2 million divided by the Company’s valuation to be determined at that time by a third party appraiser, to be nominated by both the Company and the Buyer (the “Appraiser”). The Company and the Buyer have agreed that the identity of the Appraiser shall be Murray Devine Valuation Advisers, to the extent their cost of the appraisal shall not be higher than the cost of other appraisers from the big 4 accounting firms (i.e., E&Y, KPMG, PWC and Deloitte). The Company and the Buyer have agreed to split the cost of the Appraiser.

 

The Company also released PlaySight from all of its obligations (except for those created by the Agreement) in respect of the Company, including any inter-company debts on the books, and the Buyer has released the Company from all of its obligations (except for those created by the Agreement) in respect of PlaySight and the Buyer.

 

The total loss on disposal of Foundation Sports and PlaySight amounted to $41,413,892 in the year ended April 30, 2023.

 

In April 2023, the Company determined that the technology utilized in Gameface would take substantially more financial resources and more time to bring to market and achieve profitability than originally anticipated. As a result, the goodwill and intangible assets related to Gameface were fully impaired as of April 30, 2023, resulting in an impairment loss of $11,421,817. The Company previously classified Foundation Sports in continuing operations, until December 5, 2022 when they sold 75% of Foundation Sports back to the original owners at which time it deconsolidated this subsidiary and recorded a loss on the sale. The Company also determined to dispose of the PlaySight entity during the year ended April 30, 2023. The Company completed the sale in November 2022 and recorded a loss on the sale at that time. The total loss on disposal of Foundation Sports and PlaySight amounted to $41,413,892 in the year ended April 30, 2023. The Company impaired all goodwill as of April 30, 2023.

 

On June 8, 2023, the Company entered into a merchant cash advance agreement with Meged Funding Group (“Meged”) pursuant to which the Company sold $315,689 in future receivables to Meged (the “Meged Receivables Purchased Amount”) to in exchange for payment to the Company of $210,600 in cash less fees of $10,580. The Company agreed to pay Meged $17,538 each week until the Meged Receivables Purchased Amount is paid in full.

 

2
 

 

On August 7, 2023, the Company entered into an agreement with UFS (the “UFS Agreement”) pursuant to which the Company sold $797,500 in future receivables (the “UFS Second Receivables Purchased Amount”) to UFS in exchange for payment to the Company of $550,000 in cash less fees of $50,000. The Company agreed to pay UFS $30,000 each week until the UFS Second Receivables Purchased Amount is paid in full.

 

In order to secure payment and performance of the Company’s obligations to UFS under the UFS Agreement, the Company granted to UFS a security interest in the following collateral: all accounts receivable and all proceeds as such term is defined by Article 9 of the UCC. The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to any of such collateral.

 

On September 13, 2023, the Company held a special meeting of stockholders in which the following items were approved: (i) the issuance of (i) 1,018,510 shares of the our common stock, par value $0.001 per share, that were issued on October 3, 2022, and, (ii) 11,802,002 shares of our common stock issuable upon exercise of Pre-Funded Warrants at an exercise price of $0.00001 per share, (iii) 12,820,512 shares of common stock issuable upon the exercise of 5-Year Warrants at an exercise price of $0.39 per share, (iv) 25,641,024 shares of common stock issuable upon the exercise of 7.5 Year Warrants at an exercise price of $0.43 per share and (v) 18,099,548 shares of our common stock issuable upon the exercise of 5.5 Year Warrants at an at an exercise price per share equal to $0.221 per share to Armistice Capital Master Fund Ltd and (ii) a reverse stock split of our common stock within a range of one (1)-for-ten (10) to one (1)-for-forty (40) (“Reverse Stock Split”), with the Board of Directors of the Company to set the specific ratio and determine the date for the reverse split to be effective and any other action deemed necessary to effectuate the Reverse Stock Split, without further approval or authorization of stockholders, at any time within 12 months of the special meeting date. The Company effected a 1-40 Reverse Stock Split of its common stock on September 25, 2023.

 

On September 19, 2023, the Company entered into an agreement with Meged (the “Second Meged Agreement”) pursuant to which the Company sold $423,000 in future receivables to Meged (the “Meged Second Receivable Amount”) in exchange for paying the then outstanding balance of $70,153.20 of the Meged Receivables Purchased Amount in full with the balance being retained by the Company in cash for general purposes. The Company agreed to pay Meged $15,107.14 each week until the Meged Second Receivable Amount is paid in full.

 

In order to secure payment and performance of the Company’s obligations to Meged under the Second Meged Agreement, the Company granted to Meged a security interest in the following collateral: all accounts receivable and all proceeds as such term is defined by Article 9 of the UCC. The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to any of such collateral.

 

The operations of Slinger Bag Inc., Slinger Bag Americas, Slinger Bag Canada, Slinger Bag UK, SBL and Gameface are collectively referred to as the “Company.”

 

The Company operates in the sports equipment and technology business. The Company is the owner of the Slinger Bag Launcher, which is comprised of a portable tennis ball launcher, a portable padel tennis ball launcher and a portable pickleball launcher and Gameface AI, providing AI technology and performance analytics for sports.

 

3
 

 

Results of Operations for the Three Months Ended July 31, 2023 and 2022

 

The following are the results of our operations for the three months ended July 31, 2023 as compared to 2022:

 

   For the Three Months Ended     
   July 31, 2023   July 31, 2022   Change 
   (Unaudited)   (Unaudited)     
             
Net sales  $3,120,231   $3,583,336   $(463,105)
Cost of sales   2,227,482    2,562,044    (334,562)
Gross Profit   892,749    1,021,292    (128,543)
                
Operating expenses:               
Selling and marketing expenses   242,353    756,823    (514,470)
General and administrative expenses   2,505,060    3,314,610    (809,550)
Research and development costs   -    19,425    (19,425)
Total operating expenses   2,747,413    4,090,858    (1,343,445)
Loss from operations   (1,845,664)   (3,069,566)   1,214,902 
                
Other expenses (income):               
Amortization of debt discounts   (777,192)   (2,872,222)   2,095,030 
Loss on conversion of accounts payable to common stock   (289,980)   -    (289,980)
Loss on issuance of convertible notes   -    -    - 
Gain on change in fair value of derivative liability   2,144,554    3,687,495    (1,542,941)
Interest expense - related party   -    (61,121)   61,121 
Interest expense   (69,483)   (191,303)   121,820 
Total other (income) expense   1,007,899    562,849    445,050 
                
Net loss from continuing operations  $(846,765)  $(2,506,717)  $1,659,952 

 

Net sales

 

Net sales decreased $463,105, or 13%, during the three months ended July 31, 2023 as compared to the three months ended July 31, 2022. The decrease in our online consumer marketing of Slinger Bag, coupled with the general marketplace impact resulting from the increased consumer social mobility following the lifting of all covid -related restrictions contributed to the decrease in sales. The reduction in disposable income resulting from global economic inflationary pressures also impacted on the sales of a product like Slinger Bag, priced to consumers at a minimum of $500.

 

Cost of sales and Gross income

 

Cost of sales decreased $334,562 during the three months ended July 31, 2023 as compared to the three months ended July 31, 2022, which is primarily due to the reduction in net sales. Gross income decreased $128,543, or13%, during the three months ended July 31, 2023 as compared to the three months ended July 31, 2022 due to the decrease in sales resulting from reduced on-line marketing activity and the general global recessionary economic environment.

 

4
 

 

Selling and marketing expenses

 

Selling and marketing expenses decreased $514,470, or 68%, during the three months ended July 31, 2023 as compared to the three months ended July 31, 2022. This decrease is largely driven by a decrease in social media advertising, sponsorships, and other investments in our public relations presence based on lower cash flows being generated by lower net sales. In addition, all Slinger Bag ambassador agreements came to an end contributing to a reduction in marketing expense.

 

General and administrative expenses

 

General and administrative expenses, which primarily consist of compensation (including share-based compensation) and other employee-related costs, as well as legal fees and fees for professional services, decreased $809,550 during the three months ended July 31, 2023 as compared to the three months ended July 31, 2022. This decrease is primarily driven by a decrease in share-based compensation as well as in both headcount and legal costs related to the prior year acquisition of Playsight and Foundation into the Connexa group.

 

Research and development costs

 

Research and development costs decreased $19,425 during the three months ended July 31, 2023 as compared to the three months ended July 31, 2022. This decrease is primarily driven by our need to pause all development activity in the period due to limited cash flow being available for investment.

 

Other expense

 

Total other expense increased $445,050 during the three months ended July 31, 2023 as compared to the three months ended July 31, 2022. We recorded a gain in fair value of derivatives of $2,144,554 compared to $3,687,495 in the same period in 2022. Excluding these gains during the periods to July 31,2023 and 2022, we had other expenses totaling $1,136,655 and $3,124,646 respectively. The increases in other expenses for the three months ended July 31, 2023 as compared to July 31, 2022 was a reduction in amortization of debt discounts and interest paid to related parties as well as an expense related to loss on conversion of account payable to common stock.

 

Discontinued Operations

 

Discontinued operations incorporate the impact of the divestments of both PlaySight and Gameface during the period to July 31, 2023. Total loss from discontinued operations was $0 during the three months ended July 31, 2023 as compared to $1,759,714 in the three months ended July 31, 2022. Net cash provided by discontinued operations for the three months ended July 31, 2023 and 2022 amount to $0 and $1,053,121 respectively.

 

The Company previously classified Foundation Sports in continuing operations, until December 5, 2022 when they sold 75% of Foundation Sports back to the original owners at which time it deconsolidated this subsidiary and recorded a loss on the sale. The Company also determined to dispose of the PlaySight entity during the year ended April 30, 2023. The Company completed the sale in November 2022 and recorded a loss on the sale at that time. The total loss on disposal of Foundation Sports and PlaySight amounted to $41,413,892 was fully recognized in the year ended April 30, 2023.

 

Liquidity and Capital Resources

 

Our financial statements have been prepared on a going concern basis, which assumes we will be able to realize our assets and discharge our liabilities in the normal course of business for the foreseeable future. We had an accumulated deficit of $152,597,375 as of July 31, 2023, and more losses are anticipated in the development of the business. Accordingly, there is substantial doubt about our ability to continue as a going concern. Our financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern.

 

5
 

 

The ability to continue as a going concern is dependent upon our generating profitable operations in the future and/or being able to obtain the necessary financing to meet our obligations and repay our liabilities arising from normal business operations when they become due. Management intends to finance operating costs over the next twelve months with existing cash on hand, loans from related parties, and/or private placement of debt and/or common stock. In respect to additional financing, refer to the consolidated financial statements herein. In the event that the Company is unable to successfully raise capital and/or generate revenues, the Company will likely reduce general and administrative expenses, and cease or delay its development plan until it is able to obtain sufficient financing. There can be no assurance that additional funds will be available on terms acceptable to the Company, or at all.

 

The following is a summary of our cash flows from operating, investing and financing activities for the three months ended July 31, 2023 and 2022:

 

   For the Three Months Ended 
   July 31, 2023   July 31, 2022 
Net cash provided by operating activities  $803,363   $(3,122,519)
Net cash used in investing activities   -    - 
Net cash (used in) financing activities   601,002    (3,406,129)

 

We had cash and cash equivalents of 386,459 as of July 31, 2023, as compared to $202,095 as of April 30, 2023.

 

Net cash provided by operating activities was $803,363 during the three months ended July 31, 2023, as compared to net cash used in operating activities of $(3,122,519 during the same period in 2022. Our net cash used in operating activities during the three months ended July 31, 2023 was primarily the result of our net loss of $(846,765) for the period, partially offset by our net non-cash expenses of $(404,016), incorporating the $2,144,554 reduction in change in fair value of derivative liability offset by increases in depreciation, amortization and impairment expenses, amortization of debt discounts, settlement expense and loss on settlement of accounts payable as well as changes in our current assets and liabilities related to our operations . The most notable changes occurred in in our inventory and prepaid inventory where inventory significantly decreased in the three month periods and prepaid inventory increased, as well as significant increases in accounts payable related to our cash flow issues during the respective periods.

 

Our net cash used in operating activities during the three months ended July 31, 2022 was primarily the result of our net loss of $(4,266,431) for the period and our net non-cash expenses of $(500,953) as well as the changes in our operating current assets and liabilities as indicated above.

 

We incurred no investing activities in either of the three-month periods ended July 31, 2023 and 2022.

 

Net cash used in financing activities was $(601,002) for the three months ended July 31, 2023, as compared to net cash provided by financing activities of $(3,406,129) for the same period in 2022. The changes is financing activities for the three months ended July 31, 2023 primarily consisted of $(298,834) for payments of notes payable to related parties and $(302,168) in payments of notes payable. Changes in financing activities for the three months ended July 31, 2022 consisted of proceeds of $4,195,000 resulting from issuance of common stock, $925,000 from proceeds of notes payable offset with $(15,386) in payments of notes to related parties and $(1,698,485) in payment of notes payable.

 

On June 8, 2023, the Company entered into a merchant cash advance agreement with Meged Funding Group (“Meged”) pursuant to which the Company sold $315,689 in future receivables to Meged (the “Meged Receivables Purchased Amount”) to in exchange for payment to the Company of $210,600 in cash less fees of $10,580. The Company agreed to pay Meged $17,538 each week until the Meged Receivables Purchased Amount is paid in full.

 

On August 7, 2023, the Company entered into an agreement with UFS (the “UFS Agreement”) pursuant to which the Company sold $797,500 in future receivables (the “UFS Second Receivables Purchased Amount”) to UFS in exchange for payment to the Company of $550,000 in cash less fees of $50,000. The Company agreed to pay UFS $30,000 each week until the UFS Second Receivables Purchased Amount is paid in full.

 

In order to secure payment and performance of the Company’s obligations to UFS under the UFS Agreement, the Company granted to UFS a security interest in the following collateral: all accounts receivable and all proceeds as such term is defined by Article 9 of the UCC. The Company also agreed not to create, incur, assume, or permit to exist, directly or indirectly, any lien on or with respect to any of such collateral.

 

6
 

 

Description of Indebtedness

 

Notes Payable – Related Party

 

On January 14, 2022, the Company entered into two loan agreements with Yonah Kalfa and Naftali Kalfa, each for $1,000,000, pursuant to which the Company received a total amount of $2,000,000. The loans bear interest at a rate of 8% per annum and are required to be repaid in full by July 31, 2024 or such other date as may be accepted by the lenders. The Company is not permitted to make any distribution or pay any dividends unless or until the loans are repaid in full.

 

There were $1,655,966 and $1,953,842 in outstanding borrowings from the Company’s related parties for the period ended July 31, 2023 and 2022, respectively. Accrued interest due to related parties as of July 31, 2023 and 2022 amounted to $917,957 and $917,957, respectively

 

On January 6, 2023, we sold certain of our inventory including all components, parts, additions and accessions thereto to Yonah Kalfa and Naftali Kalfa who immediately consigned it back to us in exchange for a payment of $103 per ball launcher we sell until we have paid them an aggregate total of $2,092,700, which represents payment in full of the principal amounts of the Loan Agreements (as defined below) and certain other expenses they incurred in connection with the Company.

 

Off-Balance Sheet Arrangements

 

We have no off-balance sheet arrangements.

 

Effect of Inflation and Changes in Prices

 

We do not believe that inflation and changes in prices will have a material effect on our operations.

 

Going Concern

 

Our independent registered public accounting firm auditors’ report accompanying our April 30, 2023 financial statements contained an explanatory paragraph expressing substantial doubt about our ability to continue as a going concern. The financial statements have been prepared assuming that we will continue as a going concern, which contemplates that we will realize our assets and satisfy our liabilities and commitments in the ordinary course of business.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

As a smaller reporting company, we are not required to provide this information.

 

7
 

 

Item 4. Controls and Procedures

 

Disclosure Controls and Procedures

 

The Company has adopted and maintains disclosure controls and procedures that are designed to provide reasonable assurance that information required to be disclosed in the reports filed under the Exchange Act, such as the Form 10-Q, is collected, recorded, processed, summarized and reported within the time periods specified in the rules of the Securities and Exchange Commission. The Company’s disclosure controls and procedures are also designed to ensure that such information is accumulated and communicated to management to allow timely decisions regarding required disclosure. As required under Exchange Act 13a-15, the Company’s management, including the Chief Executive Officer and Chief Financial Officer, has conducted an evaluation of the effectiveness of disclosure controls and procedures as of the end of the period covered by this report.

 

Based upon that evaluation, the Company’s Chief Executive Officer and Chief Financial Officer concluded that our internal control over financial reporting was not effective as of July 31, 2023 due to the material weaknesses that were identified and listed below.

 

Changes in Internal Control Over Financial Reporting

 

In connection with our management’s assessment of controls over financial reporting during the year ended April 30, 2023, we identified the following material weaknesses:

 

  The Company lacks adequate segregation of duties due to the small size of the organization. Further, the Company lacks an independent Board of Directors or Audit Committee to ensure adequate monitoring or oversight.
     
  The Company lacks accounting resources and controls to prevent or detect material misstatements. Specifically, the Company continues to have a material weakness in our controls over accounting for inventory due to a lack of controls over ensuring inventory movement was being processed accurately and in a timely manner, which resulted in significant audit adjustments relating to the value of our inventory and cost of sales. Further, while the Company engages service providers to assist with U.S. GAAP compliance the Company lacks resources with adequate knowledge to oversee those services. Lastly, the Company does not have sufficient resources to complete timely reconciliations and transactional reviews, which resulted in delays in the financial reporting process in the prior year.

 

To remediate the material weaknesses, we have initiated compensating controls in the near term and are enhancing and revising our existing controls, including ensuring we have sufficient management review procedures and adequate segregation of duties. These controls are still in the process of being implemented. The material weakness will not be considered remediated until the applicable controls operate for a sufficient period of time and management has concluded they are operating effectively. As a result, the material weaknesses continue to be listed as of July 31, 2023.

 

8
 

 

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings

 

On February 8, 2023, Oasis Capital, LLC (“Oasis”) filed a complaint against the Company in the United States District Court for the Southern District of New York seeking damages (i) in the amount of $764,647.53 in for an alleged breach of the terms of the 8% senior convertible note and the securities purchase agreement entered into between Oasis and the Company in connection with the Note (as defined below), which in December 2021 was increased to $600,000 in principal amount (the “Note”) and (ii) an unspecified amount of damage for an alleged breach of the exclusivity provisions of a term sheet that the Company and Oasis entered into on July 7, 2022 plus an actual damages in an amount to be proven at trial, interest and costs, reasonable attorney’s fees and such other legal and equitable relief as the court deems just and proper. On June 30, 2023, the United States District Court for the Southern District of New York granted the Company’s motion to dismiss this complaint but with leave to amended complaint. On July 31, Oasis filed an amended complaint against the Company and its Chief Executive Officer, Mike Ballardie, seeking damages in an amount to be proven at trial, interest and costs for breach of fiduciary duty and violations of Section 10(b) of the Securities and Exchange Act of 1934, as amended, and Rule 10b-5 thereunder. The Company believes the claims made in the amended complaint are without merit and the Company and Mike Ballardie are vigorously defending itself.

 

Except for the Oasis lawsuit against Mike Ballardie, we know of no pending proceedings to which any director, member of senior management, or affiliate is either a party adverse to us or has a material interest adverse to us.

 

None of our executive officers or directors have (i) been involved in any bankruptcy proceedings within the last five years, (ii) been convicted in or has pending any criminal proceedings (other than traffic violations and other minor offenses), (iii) been subject to any order, judgment or decree enjoining, barring, suspending or otherwise limiting involvement in any type of business, securities or banking activity or (iv) been found to have violated any Federal, state or provincial securities or commodities law and such finding has not been reversed, suspended or vacated.

 

Item 1A. Risk Factors

 

There have been no material changes to our risk factors as previously disclosed in Part I, Item 1A. included in our Annual Report on Form 10-K for the year ended April 30, 2023.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

The following information relates to all securities issued or sold by us since during the reporting period not registered under the Securities Act of 1933, (the “Securities Act”) pursuant to an exemption from the registration requirements of the Securities Act contained in Section 3(b) or 4(a)(2) thereof.

 

On May 23, 2023, Connexa Sports Technologies Inc. (the “Company”) issued the following shares of its common stock (“Shares”) to the following persons in transactions that were exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”), pursuant to Section 4(a)(2) of the Securities Act as transactions by an issuer not involving any public offering:

 

  1. 67,500 Shares to vendors in exchange for a reduction of $270,000 in the amount owed to such vendors;
  2. 19,750 Shares to Mike Ballardie, the Company’s chief executive officer and director, pursuant to an exercise of warrants by Mr. Ballardie;
  3. 7,250 Shares to Yona Kalfa, the Company’s chief innovation officer and director, pursuant to an exercise of warrants by Mr. Kalfa;
  4. 150 Shares to ambassadors as compensation to such ambassadors under their ambassador agreements; and
  5. 1,350 Shares to the former owner and staff of Foundation Sports Systems, LLC (“Foundation”) as final payment to such persons for 100% of the membership interests of Foundation pursuant to the Membership Interest Purchase Agreement between the Company and Charlie Ruddy dated June 18, 2021.

 

9
 

 

On June 8, 2023, the Company issued (i) 38 shares to an ambassador as compensation to such ambassador under its ambassador agreement and (ii) 43,437 shares to a lender (the “Lender”) in connection with the conversion of the outstanding principal amount of a $1,000,000 2.25% Promissory Note due April 30, 2021 into shares of common stock of the Company in exchange for a sufficient amount of shares of the Company to realize $1,500,000 in proceeds from the sale of shares of the Company’s common stock (the “Lender”).

 

On June 20, 2023, the Company issued 6,809 shares of common stock to the Lender in connection with the Conversion.

 

On July 26, 2023, the Company issued 43,437 shares of common stock to the Lender in connection with the Conversion.

 

On August 1, 2023, the Company issued 31,042 shares of common stock to Armistice upon the exercise of its Pre-Funded Warrants.

 

On August 17, 2023, the Company issued 1,876 shares of common stock to Rodney Rapson as compensation for Mr. Rapson’s advisory services under the advisory agreement between the Company and Mr. Rapson.

 

On August 31, 2023, the Company issued 42,500 shares of common stock to the Lender in connection with the Conversion.

 

On September 18, 2023, the Company issued 125,134 shares of common stock to Armistice upon the exercise of its Pre-Funded Warrants.

 

On September 19, 2023, the Company issued 9,444 shares of common stock to Armistice upon the exercise of its Pre-Funded Warrants.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety disclosures

 

Not applicable.

 

Item 5. Other Information

 

None.

 

10
 

 

Item 6. Exhibits

 

3.1   Certificate of Amendment to Certificate of Incorporation of Connexa Sports Technologies Inc., dated September 20, 2023
     

10.1

 

Standard Merchant Cash Advance Agreement, dated June 8, 2023, between Meged Funding Group and Connexa Sports Technologies Inc.

     
10.2   Standard Merchant Cash Advance Agreement, dated August 7, 2023, between Unique Funding Solutions LLC and Connexa Sports Technologies Inc.
     
10.3   Standard Merchant Cash Advance Agreement, dated September 19, 2023, between Meged Funding Group and Connexa Sports Technologies Inc.
     
31.1   Certification of Principal Executive Officer pursuant to Rule 13a-14(a) and 15d-14(a)
     
31.2   Certification of Principal Financial Officer pursuant to Rule 13a-14(a) and 15d-14(a)
     
32.1   Certification of Principal Executive Officer pursuant to 18 U.S.C. 1350
     
32.2   Certification of Principal Financial Officer pursuant to 18 U.S.C. 1350
     
101.INS   Inline XBRL Instance Document
     
101.SCH   Inline XBRL Taxonomy Extension Schema Document
     
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

11
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  CONNEXA SPORTS TECHNOLOGIES INC.
     
Dated: October 5, 2023 By: /s/ Mike Ballardie
    Mike Ballardie
    President and Chief Executive Officer
     
Dated: October 5, 2023 By: /s/ Mike Ballardie
    Mike Ballardie
   

Chief Financial Officer

(Principal Financial Officer and Principal Accounting Officer)

 

12